{
  "data": [
    {
      "link_id": "RDS00001",
      "drug_name": "Amitiza",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "lubiprostone",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-10-14",
      "manufacturer": "Sucampo Pharma Americas LLC",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "179333",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-01-07",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02447363"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00002",
      "drug_name": "Abilify Maintena",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "aripiprazole",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-09-16",
      "manufacturer": "Otsuka Pharmaceutical Co Ltd",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "178110",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-10-27",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00004",
      "drug_name": "Humira",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "adalimumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-11-05",
      "manufacturer": "AbbVie Corporation",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission",
      "date_filed": null,
      "control_number": "180556",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-11-26",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00005",
      "drug_name": "Vibativ",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "telavancin hydrochloride",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-07-14",
      "manufacturer": "Pendopharm Division of Pharmascience Inc",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "176895",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-08-12",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00006",
      "drug_name": "Arnuity Ellipta",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "fluticasone furoate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-09-21",
      "manufacturer": "Glaxosmithkline Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "177319",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-11-04",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02446561",
        "02446588"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00007",
      "drug_name": "Avastin",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Bevacizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-09-28",
      "manufacturer": "Hoffmann-La Roche Limited",
      "prescription_status": null,
      "type_submission": "SNDS",
      "date_filed": null,
      "control_number": "171255",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-10-14",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00008",
      "drug_name": "Avastin",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Bevacizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-05-15",
      "manufacturer": "Hoffmann-La Roche Limited",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "170054",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-11-30",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00009",
      "drug_name": "Basaglar",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "insulin glargine",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-09-01",
      "manufacturer": "Eli Lilly Canada Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "177405",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-11-06",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02444852 - Basaglar KwikPen",
        "02444844 - Basaglar Cartridge"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00010",
      "drug_name": "Blincyto",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "blinatumomab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-12-22",
      "manufacturer": "Amgen Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "181723",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-01-11",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02450283"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00011",
      "drug_name": "Breo Ellipta",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "fluticasone furoate, vilanterol trifenatate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-08-05",
      "manufacturer": "GlaxoSmithKline Inc",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "177501",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-09-11",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02444186"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00012",
      "drug_name": "CARBAGLU",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "carglumic acid",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-04-10",
      "manufacturer": "Orphan Europe Sarl",
      "prescription_status": null,
      "type_submission": "Priority New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "171358",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-06-12",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02439360"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00013",
      "drug_name": "Cyramza",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ramucirumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-07-16",
      "manufacturer": "Eli Lilly Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "176810",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-08-27",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "DIN 02443805, <abbr title=\"intravenous\">IV</abbr>, <abbr title=\"solution\">SOL</abbr>, 10 <abbr title=\"milligrams per millilitre\">mg/mL</abbr>"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00014",
      "drug_name": "DAKLINZA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "daclatasvir",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-08-13",
      "manufacturer": "Bristol-Myers Squibb Canada",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "172616",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-11-26",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02444747",
        "02444755"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00015",
      "drug_name": "Duaklir Genuair",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Formoterol fumarate dihydrate, aclidinium bromide",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-04-02",
      "manufacturer": "Astrazeneca Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "172711",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-05-13",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02439530"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00016",
      "drug_name": "ENTRESTO",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Valsartan and sacubitril",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-10-02",
      "manufacturer": "Novartis Pharmaceuticals Canada Inc",
      "prescription_status": null,
      "type_submission": "Priority New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "182734",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02446928",
        "02446936",
        "02446944"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00017",
      "drug_name": "EPERZAN",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Albiglutide",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-07-15",
      "manufacturer": "GlaxoSmithKline Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "165145",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-10-20",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02443635",
        "02443643"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00018",
      "drug_name": "Evotaz",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "atazanavir sulfate, cobicistat",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-09-25",
      "manufacturer": "Bristol-Myers Squibb Canada",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "180673",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-11-23",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02446731"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00019",
      "drug_name": "EYLEA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "aflibercept",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-12-10",
      "manufacturer": "Bayer Inc",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "180861",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-01-12",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00020",
      "drug_name": "Fetzima",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "levomilnacipran",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-05-08",
      "manufacturer": "Actavis Specialty Pharmaceuticals Co.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "167319",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-10-01",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02440970",
        "02440989",
        "02440997",
        "02441004"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00021",
      "drug_name": "FYCOMPA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "perampanel",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-12-01",
      "manufacturer": "Eisai Limited",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "180976",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-12-22",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00022",
      "drug_name": "Gadovist",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "gadobutrol",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-08-11",
      "manufacturer": "Bayer Inc",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "177527",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-11-05",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00023",
      "drug_name": "Gadovist",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "gadobutrol",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-10-14",
      "manufacturer": "Bayer Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "179746",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-01-11",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00024",
      "drug_name": "GALEXOS",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "simeprevir",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-10-08",
      "manufacturer": "Janssen Inc",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "179386",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-11-26",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00025",
      "drug_name": "HUMIRA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "adalimumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-12-31",
      "manufacturer": "AbbVie Corporation",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "181320",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-01-25",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00027",
      "drug_name": "INSPIOLTO RESPIMAT",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "tiotropium bromide monohydrate, olodaterol hydrochloride",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-06-01",
      "manufacturer": "Boehringer Ingelheim (Canada) Ltd Ltee",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "173315",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-06-24",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02441888"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00028",
      "drug_name": "Intuniv XR",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "guanfacine hydrochloride",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-09-08",
      "manufacturer": "Shire Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "178245",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-11-26",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00029",
      "drug_name": "Kivexa",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "lamivudine, abacavir sulfate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-10-02",
      "manufacturer": "ViiV Healthcare",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "182186",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2007-03-28",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00030",
      "drug_name": "Kalydeco",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Ivacaftor",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-06-12",
      "manufacturer": "Vertex Pharmaceuticals (canada) Incorporated",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "179589",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-08-11",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02442612",
        "02442620"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00031",
      "drug_name": "KEYTRUDA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Pembrolizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-05-19",
      "manufacturer": "Merck Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission - Notice of Compliance with conditions",
      "date_filed": null,
      "control_number": "175884",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-09-11",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "DIN: 02441152, Intravenous (IV), Powder For Solution (PWSO), 50 milligram/vial"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00032",
      "drug_name": "Mifegymiso",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "mifepristone, misoprostol",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-07-29",
      "manufacturer": "Linepharma International Limited",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "160063",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-01-13",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02444038"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00033",
      "drug_name": "Movantik",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Naloxegol oxalate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-06-02",
      "manufacturer": "Astrazeneca Canada Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "167790",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-09-11",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02442175",
        "02442167"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00034",
      "drug_name": "Ofev",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "nintedanib",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-06-25",
      "manufacturer": "Boehringer Ingelheim (Canada) Ltd Ltee",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "176043",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-09-01",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02443066",
        "02443074"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00035",
      "drug_name": "Omnitrope",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Somatropin",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-05-08",
      "manufacturer": "Sandoz Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "174817",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-05-14",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00036",
      "drug_name": "OPDIVO",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "nivolumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-09-25",
      "manufacturer": "Bristol-Myers Squibb Canada",
      "prescription_status": null,
      "type_submission": "Priority Review NDS",
      "date_filed": null,
      "control_number": "180828",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-01-19",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02446626",
        "02446634"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00037",
      "drug_name": "Ozurdex",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "dexamethasone",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-04-16",
      "manufacturer": "Allergan Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "169671",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-05-13",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not available"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00038",
      "drug_name": "Pergoveris",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "follitropin alfa, lutropin alfa",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-08-25",
      "manufacturer": "Emd Serono A Division Of Emd Inc Canada",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "175468",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-09-08",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "DIN 02445301"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00039",
      "drug_name": "PLEGRIDY",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "peginterferon beta-1a",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-08-10",
      "manufacturer": "Biogen Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "166974",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-10-30",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "DIN 02444372 Â– SC, LIQ, 63 <abbr title=\"micrograms\">&micro;g</abbr>/0.5 <abbr title=\"millilitres\">mL</abbr>",
        "DIN 02444380 - SC, LIQ, 94 &micro;g/0.5 mL",
        "DIN 02444399 - SC, LIQ, 125 &micro;g/0.5 mL",
        "DIN 02444402 - PLEGRIDY starter pack, SC, LIQ, 63 &micro;g/0.5 mL, 94 &micro;g/0.5 mL"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00040",
      "drug_name": "Prevnar 13",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Pneumococcal 13-valent conjugate vaccine (13vPnC)",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-07-27",
      "manufacturer": "Pfizer Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "177731",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-08-12",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00041",
      "drug_name": "QNASL",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "beclomethasone dipropionate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-09-18",
      "manufacturer": "Teva Canada Limited",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "168323",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-10-27",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02446324",
        "02446332"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00042",
      "drug_name": "Quinsair",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Levofloxacin",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-06-29",
      "manufacturer": "Tripex Pharmaceuticals Llc",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "171934",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-07-13",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "DIN 02442302"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00043",
      "drug_name": "REPATHA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Evolocumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-09-10",
      "manufacturer": "Amgen Canada Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "178234",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-09-22",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "DIN 02446057"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00044",
      "drug_name": "REVESTIVE",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "teduglutide",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-09-04",
      "manufacturer": "NPS Pharma Holdings Limited",
      "prescription_status": null,
      "type_submission": "Priority New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "180223",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-11-17",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02445727"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00045",
      "drug_name": "Rosiver",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Ivermectin",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-04-22",
      "manufacturer": "Galderma Canada Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "172733",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-06-24",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "DIN 02440342"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00046",
      "drug_name": "STELARA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ustekinumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-12-10",
      "manufacturer": "Janssen Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "180654",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-01-21",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00047",
      "drug_name": "SmofKabiven",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "l-alanine, dextrose, fish oil, glycine, l-arginine, l-histidine, l-isoleucine, l-leucine, l-phenylalanine, l-proline, l-serine, l-threonine, l-tryptophan, l-valine, magnesium sulfate, l-methionine, olive oil, potassium chloride, sodium glycerophosphate, soybean oil, taurine, l-tyrosine, sodium acetate trihydrate, zinc sulfate heptahydrate, medium-chain triglycerides, l-lysine, calcium chloride dihydrate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-05-06",
      "manufacturer": "Fresenius Kabi Canada A Division Of Calea Ltd.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "174522",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-06-17",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "DIN 02440695"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00048",
      "drug_name": "SODIUM NITRITE INJECTION USP",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "sodium nitrite",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-04-28",
      "manufacturer": "Hope Pharmaceuticals Ltd",
      "prescription_status": null,
      "type_submission": "EU NDS",
      "date_filed": null,
      "control_number": "174143",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-06-24",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "DIN 02440466"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00049",
      "drug_name": "Spiriva Respimat",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "tiotropium bromide monohydrate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-05-20",
      "manufacturer": "Boehringer Ingelheim (Canada) Ltd Ltee",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "175084",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-06-17",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00050",
      "drug_name": "STRENSIQ",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "asfotase alfa",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-08-14",
      "manufacturer": "Alexion Pharma International Sarl",
      "prescription_status": null,
      "type_submission": "New Drug Submission filed under the Notice of Compliance with Conditions (NOC/c) policy.",
      "date_filed": null,
      "control_number": "179340",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-08-27",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02444607, 12 <abbr title=\"milligrams\">mg</abbr>/0.3 <abbr title=\"millilitres\">mL</abbr> (40 <abbr title=\"milligrams per millilitre\">mg/mL</abbr>)",
        "02444615, 18 mg/0.45 mL (40 mg/mL)",
        "02444623, 28 mg/0.7 mL (40 mg/mL)",
        "02444631, 40 mg/1 mL (40 mg/mL)",
        "02444658, 80 mg/0.8 mL (100 mg/mL)"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00051",
      "drug_name": "STRIBILD",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "emtricitabine, tenofovir disoproxil fumarate, elvitegravir, cobicistat",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-05-08",
      "manufacturer": "Gilead Sciences Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "175142",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-06-12",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00052",
      "drug_name": "Technivie",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ritonavir, paritaprevir, ombitasvir",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-10-20",
      "manufacturer": "AbbVie Corporation",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "183275",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-01-12",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02447711"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00053",
      "drug_name": "TOUJEO SoloSTAR",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "insulin glargine (rDNA origin)",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-05-28",
      "manufacturer": "Sanofi-aventis Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "173316",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-09-28",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02441829"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00054",
      "drug_name": "TRULICITY",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "dulaglutide",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-11-10",
      "manufacturer": "Eli Lilly Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "168671",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-11-18",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02448572 - 0.75 <abbr title=\"milligrams\">mg</abbr>/ 0.5 <abbr title=\"millilitres\">mL</abbr> - Prefilled Syringe",
        "02448580 - 1.5 mg / 0.5 mL - Prefilled Syringe",
        "02448599 - 0.75 mg / 0.5 mL - Single Use Pen",
        "02448602 - 1.5 mg / 0.5 mL - Single Use Pen"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00055",
      "drug_name": "Varithena",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "carbon dioxide, oxygen, polidocanol",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-08-04",
      "manufacturer": "Provensis Ltd.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "177359",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-11-05",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02444267"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00056",
      "drug_name": "VECTIBIX",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "panitumumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-08-31",
      "manufacturer": "Amgen Canada Inc.",
      "prescription_status": null,
      "type_submission": "SNDS",
      "date_filed": null,
      "control_number": "166626",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-09-22",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00058",
      "drug_name": "Viibryd",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Vilazodone HCl",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-07-16",
      "manufacturer": "Forest Laboratories Canada Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "176820",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-11-30",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02442734",
        "02443732",
        "02443740",
        "02443759",
        "02443767"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00059",
      "drug_name": "Xgeva",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "denosumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-10-19",
      "manufacturer": "Amgen Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "176891",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-11-26",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00060",
      "drug_name": "Xtandi",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Enzalutamide",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-04-15",
      "manufacturer": "Astellas Pharma Canada Inc",
      "prescription_status": null,
      "type_submission": "Priority Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "177983",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-05-14",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00061",
      "drug_name": "Yasmin Plus",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ethinyl estradiol, drospirenone, levomefolate calcium",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-06-18",
      "manufacturer": "Bayer Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "149696",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-01-15",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02442744"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00062",
      "drug_name": "Zerbaxa",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "tazobactam sodium, ceftolozane sulfate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-09-30",
      "manufacturer": "Merck Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "178006",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02446901"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00063",
      "drug_name": "Zevtera",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ceftobiprole medocaril",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-09-24",
      "manufacturer": "Basilea Pharmaceutica International AG",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "178459",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-11-24",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02446685"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00068",
      "drug_name": "BLEXTEN",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "bilastine",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-04-21",
      "manufacturer": "Aralez Pharmaceuticals Trading Dac",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "184231",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-26",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02454130"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00064",
      "drug_name": "Ziagen",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "abacavir sulfate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-07-21",
      "manufacturer": "ViiV Healthcare ULC",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "176901",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2015-12-11",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00065",
      "drug_name": "ADREVIEW",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Iobenguane (123I) Injection",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-04-07",
      "manufacturer": "GE Healthcare Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "171024",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-04-14",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00067",
      "drug_name": "BELKYRA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "deoxycholic acid",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-07-24",
      "manufacturer": "Kythera Biopharmaceuticals Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "177129",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-13",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02443910"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00069",
      "drug_name": "BRIDION",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Sugammadex",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-02-05",
      "manufacturer": "Merck Canada Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "180385",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-20",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02451816"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00070",
      "drug_name": "BRIVLERA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "brivaracetam",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-03-09",
      "manufacturer": "UCB Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "183355",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-09",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02452936",
        "02452944",
        "02452952",
        "02452960",
        "02452979",
        "02452987",
        "02452995"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00071",
      "drug_name": "BYDUREON",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "exenatide extended-release",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-10-30",
      "manufacturer": "Astrazeneca Canada Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "167695",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-04",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02448610"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00072",
      "drug_name": "COTELLIC",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "cobimetinib fumarate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-02-22",
      "manufacturer": "Hoffmann La Roche Limited",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "182788",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-04-11",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02452340"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00073",
      "drug_name": "COSENTYX SA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Secukinumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-04-20",
      "manufacturer": "Novartis Pharmaceuticals Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "184144",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-04-28",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00077",
      "drug_name": "ESBRIET",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "pirfenidone",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-05-02",
      "manufacturer": "Hoffmann-La Roche Limited",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "184128",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-06-26",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00074",
      "drug_name": "COSENTYX PSA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Secukinumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-04-20",
      "manufacturer": "Novartis Pharmaceuticals Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "184142",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-04-28",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00075",
      "drug_name": "DEXEDRINE TABLETS, DEXEDRINE SPANSULES",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "dextroamphetamine sulfate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-03-22",
      "manufacturer": "Paladin Labs Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "183401",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-04-29",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "01924516",
        "01924559",
        "01924567"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00076",
      "drug_name": "ENTYVIO",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "vedolizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-03-22",
      "manufacturer": "Takeda Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "183836",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-04-19",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00176",
      "drug_name": "panobinostat (*Farydak)",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "panobinostat",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Submmision cancelled",
      "decision_descr": null,
      "date_decision": "2016-06-23",
      "manufacturer": "Novartis Pharmaceuticals Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "187504",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-14",
      "footnotes": 0,
      "summary_title": "Summary of Cancellation for panobinostat (*Farydak)",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00078",
      "drug_name": "FORXIGA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Dapagliflozin",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-12-09",
      "manufacturer": "Astrazeneca Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "180845",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-16",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00079",
      "drug_name": "FORXIGA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Dapagliflozin",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-12-02",
      "manufacturer": "Astrazeneca Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "180758",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00080",
      "drug_name": "GRASTOFIL",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "filgrastim",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-12-07",
      "manufacturer": "Apotex Incorporated",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "156897",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02441489"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00081",
      "drug_name": "HUMIRA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "adalimumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-02-26",
      "manufacturer": "AbbVie Corporation",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission",
      "date_filed": null,
      "control_number": "182854",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-04-01",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00082",
      "drug_name": "IBRANCE",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "palbociclib",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-03-16",
      "manufacturer": "Pfizer Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "182048",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-27",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02453150",
        "02453169",
        "02453177"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00083",
      "drug_name": "ICLUSIG",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ponatinib hydrochloride",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-04-02",
      "manufacturer": "Ariad Pharmaceuticals Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "165121",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-19",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02437333",
        "02437341"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00092",
      "drug_name": "MEKINIST",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "trametinib",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-03-11",
      "manufacturer": "Novartis Pharmaceuticals Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "183167",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-04-22",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00084",
      "drug_name": "IDELVION",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Coagulation Factor IX (Recombinant), Albumin Fusion Protein (rIX-FP)",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-01-26",
      "manufacturer": "CSL Behring Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "180793",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-19",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02451336",
        "02451344",
        "02451352",
        "02451360"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00085",
      "drug_name": "IMBRUVICA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ibrutinib",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-03-31",
      "manufacturer": "Janssen Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "183766",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-04-21",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00086",
      "drug_name": "JARDIANCE",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "empagliflozin",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-07-23",
      "manufacturer": "Boehringer Ingelheim (Canada) Ltd Ltee.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "162552",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-16",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02443937",
        "02443945"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00087",
      "drug_name": "KEYTRUDA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Pembrolizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-05-06",
      "manufacturer": "Merck Canada",
      "prescription_status": null,
      "type_submission": "Priority Review - Supplemental New Drug Submission",
      "date_filed": null,
      "control_number": "187844",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-27",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00088",
      "drug_name": "KEYTRUDA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Pembrolizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-06-22",
      "manufacturer": "Merck Canada",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission - Confirmatory (SNDS-c)",
      "date_filed": null,
      "control_number": "185303",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-07-18",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00089",
      "drug_name": "KOVALTRY",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Antihemophilic Factor (Recombinant)",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-01-27",
      "manufacturer": "Bayer Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "181693",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-02",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02451441, IV, PWSO, 250 <abbr title=\"International Units per vial\">IU/vial</abbr> (Adapter);",
        "02451468, IV, PWSO, 500 <abbr title=\"International Units per vial\">IU/vial</abbr> (Adapter);",
        "02451476, IV, PWSO, 1,000 <abbr title=\"International Units per vial\">IU/vial</abbr> (Adapter);",
        "02451484, IV, PWSO, 2,000 <abbr title=\"International Units per vial\">IU/vial</abbr> (Adapter);",
        "02451492, IV, PWSO, 3,000 <abbr title=\"International Units per vial\">IU/vial</abbr> (Adapter);",
        "02451603, IV, PWSO, 250 <abbr title=\"International Units per vial\">IU/vial</abbr> (Bioset);",
        "02451611, IV, PWSO, 500 <abbr title=\"International Units per vial\">IU/vial</abbr> (Bioset);",
        "02451638, IV, PWSO, 1,000 <abbr title=\"International Units per vial\">IU/vial</abbr> (Bioset);",
        "02451646, IV, PWSO, 2000 <abbr title=\"International Units per vial\">IU/vial</abbr> (Bioset);",
        "02451654, IV, PWSO, 3,000 <abbr title=\"International Units per vial\">IU/vial</abbr> (Bioset)."
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00090",
      "drug_name": "LENVIMA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "lenvatinib mesylate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-12-22",
      "manufacturer": "Eisai Limited",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "180877",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-19",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02450291",
        "02450305",
        "02450313",
        "02450321"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00091",
      "drug_name": "LUNESTA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "eszopiclone",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-03-17",
      "manufacturer": "Sunovion Pharmaceuticals Canada Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "127292",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-04-28",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02453207",
        "02453215",
        "02453223"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00093",
      "drug_name": "NIASTASE RT",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Eptacog Alfa (activated)",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-11-25",
      "manufacturer": "Novo Nordisk Canada Inc.",
      "prescription_status": null,
      "type_submission": "SNDS",
      "date_filed": null,
      "control_number": "180663",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-04",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00094",
      "drug_name": "OPDIVO",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Nivolumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-04-29",
      "manufacturer": "Bristol-Myers Squibb Canada",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "183397",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-11",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00095",
      "drug_name": "OPDIVO",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "nivolumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-04-25",
      "manufacturer": "Bristol-Myers Squibb Canada",
      "prescription_status": null,
      "type_submission": "Supplemental new drug submission",
      "date_filed": null,
      "control_number": "189821",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02446626",
        "02446634"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00326",
      "drug_name": "Aermony RespiClick",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "fluticasone propionate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-08-22",
      "manufacturer": "Teva Canada Limited",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "197873",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-02-07",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02467895",
        "02467909",
        "02467917"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00096",
      "drug_name": "OPDIVO",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Nivolumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-02-26",
      "manufacturer": "Bristol Myers Squibb Canada",
      "prescription_status": null,
      "type_submission": "Priority Review NDS",
      "date_filed": null,
      "control_number": "186625",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-03-24",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02446626",
        "02446634"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00097",
      "drug_name": "ORKAMBI",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ivacaftor, lumacaftor",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-01-26",
      "manufacturer": "Vertex Pharmaceuticals (Canada) Incorporated",
      "prescription_status": null,
      "type_submission": "Priority New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "181715",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-04-12",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02451379"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00098",
      "drug_name": "OTEZLA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "apremilast",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-06-10",
      "manufacturer": "Celgene Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "164228",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-04",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00099",
      "drug_name": "PRALUENT",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "alirocumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-04-11",
      "manufacturer": "sanofi-aventis Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "183116",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-04-28",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02453754",
        "02453762",
        "02453819",
        "02453835"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00100",
      "drug_name": "PRAXBIND",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "idarucizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-04-29",
      "manufacturer": "Boehringer (Canada) Ingelheim Ltd.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "182503",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-17",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02454343"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00101",
      "drug_name": "RAVICTI",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "glycerol phenylbutyrate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-03-18",
      "manufacturer": "Horizon Pharma Ireland Ltd.",
      "prescription_status": null,
      "type_submission": "Priority New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "174219",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-13",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02453304"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00102",
      "drug_name": "S.O.S. NALOXONE HYDROCHLORIDE INJECTION",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "naloxone HCl",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-03-22",
      "manufacturer": "Sandoz Canada Incorporated",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "191331",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-04-29",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02453258",
        "02453266"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00103",
      "drug_name": "SMOFKABIVEN ELECTROLYTE FREE (5.1% Amino Acids, 17.7% Dextrose, 3.8% Lipids)",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "<dd>L-alanine, dextrose, fish oil, glycine, L-arginine, L-histidine, L-isoleucine, L-leucine, L-phenylalanine HCl, L-proline, L-serine, L-threonine, L-tryptophan, L-valine, L-methionine, olive oil, soybean oil, taurine, L-tyrosine, medium-chain triglycerides, L-lysine</dd>",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-04-30",
      "manufacturer": "Fresenius Kabi Canada Ltd.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "168934",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-04-21",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "DIN 02440687"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00104",
      "drug_name": "SOMATULINE AUTOGEL",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "lanreotide acetate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-09-28",
      "manufacturer": "Ipsen Biopharm Limited",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "178506",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-03-11",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00105",
      "drug_name": "SUNVEPRA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "asunaprevir",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-03-09",
      "manufacturer": "Bristol-Myers Squibb Canada",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "172617",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-04",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02452294"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00106",
      "drug_name": "SYNFLORIX",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Pneumococcal conjugate vaccine (Non-Typeable Haemophilus influenzae (NTHi) protein D, diphtheria or tetanus toxoid conjugates) adsorbed",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-03-11",
      "manufacturer": "GlaxoSmithKline Inc.",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "184101",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-09",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not available"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00107",
      "drug_name": "TRUVADA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "emtricitabine, tenofovir disoproxil fumarate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-02-26",
      "manufacturer": "Gilead Sciences Canada Inc",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "187173",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-03-30",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00108",
      "drug_name": "UPTRAVI",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "selexipag",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-01-20",
      "manufacturer": "Actelion Pharmaceuticals Ltd.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "182114",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-03-16",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02451158",
        "02451166",
        "02451174",
        "02451182",
        "02451190",
        "02451204",
        "02451212",
        "02451220"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00109",
      "drug_name": "VIACORAM",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "perindopril arginine, amlodipine besylate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-01-08",
      "manufacturer": "Servier Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "180798",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-03-14",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02451530",
        "02451549",
        "02451557"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00110",
      "drug_name": "VISANNE",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "dienogest",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-02-18",
      "manufacturer": "Bayer Inc",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "182613",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-24",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00111",
      "drug_name": "VITAMIN A (100,000 <abbr title=\"international units\">IU</abbr>) and VITAMIN E (20 <abbr title=\"international units\">IU</abbr>) ORAL LIQUID PREPARATION",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "vitamin a, vitamin e",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-04-06",
      "manufacturer": "Nutricorp International",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "167923",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-04",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02453584"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00112",
      "drug_name": "VITAMIN A (200,000 IU) and VITAMIN E (40 IU) ORAL LIQUID PREPARATION",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "vitamin a, vitamin e",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-04-06",
      "manufacturer": "Nutricorp International",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "167924",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02453592"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00118",
      "drug_name": "EDURANT",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Rilpivirine hydrochloride",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-05-10",
      "manufacturer": "Janssen Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "185031",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-06-07",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00113",
      "drug_name": "XIGDUO",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "metformin hcl, dapagliflozin",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-04-12",
      "manufacturer": "Astrazeneca Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "191680",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-02",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00114",
      "drug_name": "XTORO",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Finafloxacin",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-03-11",
      "manufacturer": "Alcon Canada Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "172450",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-19",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02452928"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00115",
      "drug_name": "AFINITOR",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "everolimus",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-05-17",
      "manufacturer": "Novartis Pharmaceuticals Canada Inc.",
      "prescription_status": null,
      "type_submission": "Priority Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "188629",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-06-14",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00116",
      "drug_name": "DYSPORT",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "AbobotulinumtoxinA",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-06-13",
      "manufacturer": "Ipsen Biopharm Limited",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission",
      "date_filed": null,
      "control_number": "185877",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-06-24",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02387735 - 300Â U Vial",
        "02456117 - 500Â U Vial"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00117",
      "drug_name": "DYSPORT",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "AbobotulinumtoxinA",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-06-13",
      "manufacturer": "Ipsen Biopharm Limited",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission",
      "date_filed": null,
      "control_number": "185878",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-06-24",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02387735 - 300Â U Vial",
        "02456117 - 500Â U Vial"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00119",
      "drug_name": "KYPROLIS",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "carfilzomib",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-01-15",
      "manufacturer": "Amgen Canada Inc.",
      "prescription_status": null,
      "type_submission": "Priority New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "184479",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-06-08",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02451034"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00120",
      "drug_name": "METOJECT SUBCUTANEOUS",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "methotrexate sodium",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-05-17",
      "manufacturer": "Medexus Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "173985",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-06-22",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02454750",
        "02454769",
        "02454777",
        "02454823",
        "02454831",
        "02454858",
        "02454866",
        "02454874"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00121",
      "drug_name": "MSM Blood Donor Deferral",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-06-16",
      "manufacturer": "",
      "prescription_status": null,
      "type_submission": "Application for an Authorization Amendment",
      "date_filed": null,
      "control_number": "193844 & 193718",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-06-20",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [],
      "bullet_list": null
    },
    {
      "link_id": "RDS00122",
      "drug_name": "NATESTO",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "testosterone",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-01-05",
      "manufacturer": "Acerus Pharmaceuticals Srl",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "181379",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-06-01",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02450550"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00123",
      "drug_name": "TALTZ",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Ixekizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-05-25",
      "manufacturer": "Eli Lilly Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "184993",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-06-09",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02455102 - autoinjector",
        "02455110 - syringe"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00124",
      "drug_name": "INFLECTRA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "infliximab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-06-10",
      "manufacturer": "Celltrion Healthcare Co. Ltd.",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission",
      "date_filed": null,
      "control_number": "184564",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-07-06",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "184564"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00125",
      "drug_name": "INVEGA SUSTENNA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "paliperidone palmitate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-11-27",
      "manufacturer": "Janssen Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "180916",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-02-11",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00132",
      "drug_name": "REVOLADE",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Eltrombopag olamine",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-05-06",
      "manufacturer": "Glaxosmithkline Inc",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "174705",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-08-02",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00126",
      "drug_name": "INVEGA TRINZA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "paliperidone palmitate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-06-23",
      "manufacturer": "Janssen Inc",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "185929",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-08-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02455943",
        "02455986",
        "02455994",
        "02456001"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00127",
      "drug_name": "INVOKAMET",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "metformin hcl, canagliflozin",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-06-01",
      "manufacturer": "Janssen Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "185383",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-07-25",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02455404",
        "02455412",
        "02455420",
        "02455439",
        "02455447",
        "02455455"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00128",
      "drug_name": "JAKAVI",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ruxolitinib phosphate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-11-24",
      "manufacturer": "Novartis Pharmaceuticals Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "180682",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-07-18",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00129",
      "drug_name": "KEYTRUDA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Pembrolizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-04-15",
      "manufacturer": "Merck Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "186275",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-04-28",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00130",
      "drug_name": "LYNPARZA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "olaparib",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-04-29",
      "manufacturer": "AstraZeneca Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "182823",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-07-26",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02454408"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00131",
      "drug_name": "NUCALA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "mepolizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-12-03",
      "manufacturer": "Glaxosmithkline Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "179850",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-05-19",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02449781"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00133",
      "drug_name": "RIXUBIS",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Recombinant Coagulation Factor IX (rFIX), Nonacog gamma",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-07-05",
      "manufacturer": "Baxalta Canada Corporation",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drugs Submission (SNDS)",
      "date_filed": null,
      "control_number": "186641",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-07-29",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00134",
      "drug_name": "SIMPONI",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Golimumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-06-23",
      "manufacturer": "Janssen Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "185908",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-07-11",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00135",
      "drug_name": "TAGRISSO",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "osimertinib",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-07-05",
      "manufacturer": "AstraZeneca Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "188171",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02456214",
        "02456222"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00136",
      "drug_name": "ZONTIVITY",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "vorapaxar sulfate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-05-13",
      "manufacturer": "Merck Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "179320",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-07-06",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02454815"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00138",
      "drug_name": "BETEFLAM",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "betamethasone valerate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-12-04",
      "manufacturer": "Cipher Pharmaceuticals Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "180711",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-07-22",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02449773"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00139",
      "drug_name": "BRILINTA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ticagrelor",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-05-30",
      "manufacturer": "AstraZeneca Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "184666",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-07-13",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02455005"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00140",
      "drug_name": "CINQAIR",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Reslizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-07-20",
      "manufacturer": "Teva Canada Limited",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "185873",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-07-28",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02456419"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00141",
      "drug_name": "DAKLINZA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "daclatasvir",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-05-17",
      "manufacturer": "Bristol-Myers Squibb Canada",
      "prescription_status": null,
      "type_submission": "Priority Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "189173",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-07-18",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02444747",
        "02444755"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00143",
      "drug_name": "DARZALEX",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Daratumumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-06-29",
      "manufacturer": "Janssen Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "187648",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-07-28",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02455951, IV, SOL, 100 mg/5 mL",
        "02455978, IV, SOL, 400 mg/20 mL"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00158",
      "drug_name": "ZEMAIRA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Alpha1-Proteinase Inhibitor (Human)",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-09-21",
      "manufacturer": "CSL Behring Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "188216",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02457911"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00144",
      "drug_name": "ELOCTATE",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Antihemophilic Factor (Recombinant BDD), Fc Fusion Protein",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-07-08",
      "manufacturer": "Biogen Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission",
      "date_filed": null,
      "control_number": "186957",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-08-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00145",
      "drug_name": "EMPLICITI",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Elotuzumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-06-21",
      "manufacturer": "Bristol Myers Squibb Canada",
      "prescription_status": null,
      "type_submission": "Priority New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "188144",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-07-18",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02455919",
        "02455927"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00146",
      "drug_name": "GENVOYA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "emtricitabine, elvitegravir, cobicistat, tenofovir alafenamide fumarate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-11-27",
      "manufacturer": "Gilead Sciences Canada Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "181399",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-02-02",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02449498"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00147",
      "drug_name": "ALPROLIX",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Coagulation Factor IX (Recombinant), Fc Fusion Protein",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-08-16",
      "manufacturer": "Biogen Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug SubmissionÂ (SNDS)",
      "date_filed": null,
      "control_number": "188247",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-08-16",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00148",
      "drug_name": "NINLARO",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ixazomib citrate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-08-04",
      "manufacturer": "Takeda Canada Inc",
      "prescription_status": null,
      "type_submission": "Priority New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "190498",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-09-14",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02456818",
        "02456826",
        "02456796"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00149",
      "drug_name": "SMOFKABIVEN PERIPHERAL",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "l-alanine, dextrose, fish oil, glycine, l-arginine, l-histidine hcl, l-isoleucine, l-leucine hcl, l-phenylalanine, l-proline, l-threonine, l-tryptophan, l-valine, magnesium sulfate, l-methionine, olive oil, potassium chloride, serine, sodium glycerophosphate, soybean oil, taurine, l-tyrosine, sodium acetate trihydrate, zinc sulfate heptahydrate, medium-chain triglycerides, l-lysine, calcium chloride dihydrate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-07-05",
      "manufacturer": "Fresenius Kabi Canada Ltd.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "177540",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-08-24",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02456206"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00150",
      "drug_name": "IMBRUVICA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ibrutinib",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-07-28",
      "manufacturer": "Janssen Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "179136",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-08-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00151",
      "drug_name": "IMBRUVICA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ibrutinib",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-07-19",
      "manufacturer": "Janssen Inc.",
      "prescription_status": null,
      "type_submission": "Priority Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "190730",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-08-17",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00152",
      "drug_name": "JARDIANCE",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "empagliflozin",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-07-27",
      "manufacturer": "Boehringer Ingelheim (Canada) Ltd.",
      "prescription_status": null,
      "type_submission": "Priority Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "190736",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-08-18",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00153",
      "drug_name": "BRENZYS (sb4)",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "etanercept",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-06-01",
      "manufacturer": "Samsung Bioepis Co., Ltd",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "184793",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00154",
      "drug_name": "BEPREVE",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "bepotastine besilate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-07-27",
      "manufacturer": "Bausch & Lomb Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "179294",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02456532"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00155",
      "drug_name": "ENSTILAR",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "betamethasone dipropionate, calcipotriol monohydrate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-09-13",
      "manufacturer": "Leo Pharma Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "182839",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02457393"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00156",
      "drug_name": "WILATE",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Human von Willebrand Factor (VWF) and Human Coagulation Factor VIII (FVIII)",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-08-19",
      "manufacturer": "Octapharma Pharmazeutika Produktionsges.m.b.H",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "188627",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00157",
      "drug_name": "GENTAMICIN INJECTION USP",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "gentamicin sulfate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-08-19",
      "manufacturer": "Teligent OÃœ",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "183885",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02457008"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00159",
      "drug_name": "SOMAVERT",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "pegvisomant for injection",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-09-16",
      "manufacturer": "Pfizer Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "188597",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00160",
      "drug_name": "MDK-NITISINONE",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "nitisinone",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-09-20",
      "manufacturer": "Mendelikabs Inc",
      "prescription_status": null,
      "type_submission": "Priority New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "190564",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02457717",
        "02457725",
        "02457733"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00161",
      "drug_name": "GIOTRIF",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "afatinib",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-08-25",
      "manufacturer": "Boehringer Ingelheim (Canada) Ltd./Ltee",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "187656",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00162",
      "drug_name": "RUPATADINE",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Rupatadine fumarate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-07-20",
      "manufacturer": "Pediapharm Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "186488",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02456451",
        "02456478"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00163",
      "drug_name": "ALECENSARO",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Alectinib",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-09-29",
      "manufacturer": "Hoffmann La Roche Limited",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "189442",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02458136"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00166",
      "drug_name": "VENCLEXTA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "venetoclax",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-09-30",
      "manufacturer": "AbbVie Corporation",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "190761",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02458039",
        "02458047",
        "02458055",
        "02458063"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00167",
      "drug_name": "CORTIMENT",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Budesonide",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-06-20",
      "manufacturer": "Ferring Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "183534",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02455889"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00175",
      "drug_name": "XIGDUO",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "metformin hcl, dapagliflozin",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-12-10",
      "manufacturer": "AstraZeneca Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "175649",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-14",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02449935",
        "02449943"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00168",
      "drug_name": "HOLKIRA PAK",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ritonavir, paritaprevir, ombitasvir, dasabuvir",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-04-11",
      "manufacturer": "AbbVie Corporation",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "184061",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00169",
      "drug_name": "IZBA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Travoprost",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-09-23",
      "manufacturer": "Alcon Canada Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "180846",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02457997"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00170",
      "drug_name": "DESCOVY",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "emtricitabine, tenofovir alafenamide fumarate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-04-29",
      "manufacturer": "Gilead Sciences Canada Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "184444",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02454416",
        "02454424"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00171",
      "drug_name": "HEMANGIOL",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "propranolol hcl",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-09-23",
      "manufacturer": "Pierre Fabre Dermo-cosmetique Canada Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "170663",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02457857"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00172",
      "drug_name": "OPDIVO",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Nivolumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-10-26",
      "manufacturer": "Bristol-Myers Squibb Canada",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "189307",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00173",
      "drug_name": "ZEPATIER",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "grazoprevir, elbasvir",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-01-19",
      "manufacturer": "Merck Canada Inc",
      "prescription_status": null,
      "type_submission": "Priority New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "185866",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02451131"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00174",
      "drug_name": "HARVONI",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ledipasvir, sofosbuvir",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-06-14",
      "manufacturer": "Gilead Sciences Canada Inc",
      "prescription_status": null,
      "type_submission": "Priority Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "190246",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00177",
      "drug_name": "REMSIMA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "infliximab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-08-05",
      "manufacturer": "Celltrion Healthcare Co. Ltd.",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission",
      "date_filed": null,
      "control_number": "184568",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-14",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00178",
      "drug_name": "PANZYGA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Immunoglobulin G 10%",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-06-24",
      "manufacturer": "Octapharma Pharmazeutica Produktionsges m.b.H.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "184566",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-14",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02456087, IV, SOL, 100 mg/mL."
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00179",
      "drug_name": "MONOPROST",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "latanoprost",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-07-07",
      "manufacturer": "Laboratoires Thea",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "173577",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-14",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02456230"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00180",
      "drug_name": "JADENU",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "deferasirox",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-02-24",
      "manufacturer": "Novartis Pharmaceuticals Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "179088",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-14",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02452219",
        "02452227",
        "02452235"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00181",
      "drug_name": "EPCLUSA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "sofosbuvir, velpatasvir",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-07-11",
      "manufacturer": "Gilead Sciences Canada Inc",
      "prescription_status": null,
      "type_submission": "Priority New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "190521",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-14",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "190521"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00182",
      "drug_name": "ataluren (*Translarna)",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ataluren",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Submmision cancelled",
      "decision_descr": null,
      "date_decision": null,
      "manufacturer": "PTC Therapeutics",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "186992",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-14",
      "footnotes": 0,
      "summary_title": "Summary of Cancellation: ataluren (*Translarna)",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00183",
      "drug_name": "OCTAGAM 10%",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Immune Globulin Intravenous [Human]",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-11-03",
      "manufacturer": "Octapharma Pharmazeutika Produktionsges.m.b.H",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "190893",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-24",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00211",
      "drug_name": "Synjardy",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "metformin HCl, empagliflozin",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-07-29",
      "manufacturer": "Boehringer Ingelheim (Canada) Ltd Ltee",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "186812",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-02-17",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02456575",
        "02456583",
        "02456591",
        "02456605",
        "02456613",
        "02456621"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00184",
      "drug_name": "VOLIBRIS",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Ambrisentan",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-02-05",
      "manufacturer": "Glaxosmithkline Inc",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "182566",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-24",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00185",
      "drug_name": "NALOXONE HYDROCHLORIDE NASAL SPRAY",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "naloxone hcl",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-10-03",
      "manufacturer": "Adapt Pharma Operations Limited",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "193199",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-11-29",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02458179",
        "02458187"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00189",
      "drug_name": "KYPROLIS",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "carfilzomib",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-11-22",
      "manufacturer": "Amgen Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "190434",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-12-16",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00186",
      "drug_name": "NITISINONE TABLETS",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Nitisinone",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-11-04",
      "manufacturer": "Cycle Pharmaceuticals Ltd",
      "prescription_status": null,
      "type_submission": "Priority New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "193770",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-12-02",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02458616",
        "02458624",
        "02458632"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00187",
      "drug_name": "AREPANRIX H5N1",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "AS03-adjuvanted Quebec H5N1 influenza vaccine",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-11-07",
      "manufacturer": "ID Biomedical Corporation of Quebec",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "190247",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-12-06",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "DIN not available"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00188",
      "drug_name": "ADYNOVATE",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Antihemophilic Factor (Recombinant), Pegylated",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-11-17",
      "manufacturer": "Baxalta Canada Corporation",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "189709",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-12-06",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02459035, IV, PWSO, 250 IU/vial",
        "02459043, IV, PWSO, 500 IU/vial",
        "02459051, IV, PWSO, 1000 IU/vial",
        "02459078, IV, PWSO, 2000 IU/vial"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00190",
      "drug_name": "MOVAPO",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "apomorphine HCl",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-11-22",
      "manufacturer": "Paladin Labs Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "190560",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-12-16",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02459132",
        "02459140"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00191",
      "drug_name": "QTERN",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "dapagliflozin, saxagliptin",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-11-22",
      "manufacturer": "AstraZeneca Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "189590",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-12-16",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02459175",
        "02459183"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00192",
      "drug_name": "BAT",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-12-08",
      "manufacturer": "Cangene Corporation",
      "prescription_status": null,
      "type_submission": "Extraordinary Use New Drugs Submission (EUNDS)",
      "date_filed": null,
      "control_number": "190645",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-12-16",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02459612, IV, SOL, 50 mL vial<ul><li>minimum potency of 4,500 Units/vial serotype A antitoxin;</li><li>minimum potency of 3,300 Units/vial serotype B antitoxin;</li><li>minimum potency of 3,000 Units/vial serotype C antitoxin;</li><li>minimum potency of 600 Units/vial serotype D antitoxin;</li><li>minimum potency of 5,100 Units/vial serotype E antitoxin;</li><li>minimum potency of 3,000 Units/vial serotype F antitoxin;</li><li>minimum potency of 600 Units/vial serotype G antitoxin.</li></ul>"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00193",
      "drug_name": "ZINBRYTA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Daclizumab beta",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-12-08",
      "manufacturer": "Biogen Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "190458",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-12-30",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02459620 (pre-filled syringe)",
        "02459639 (pre-filled pen)"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00194",
      "drug_name": "HUMIRA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Adalimumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-11-15",
      "manufacturer": "Abbvie Corporation",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "190514",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-01-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00195",
      "drug_name": "STELARA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Ustekinumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-12-12",
      "manufacturer": "Janssen Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "190732",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-01-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02459671"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00196",
      "drug_name": "REVLIMID",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "lenalidomide",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-12-14",
      "manufacturer": "Celgene Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "190743",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-01-09",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02459418"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00197",
      "drug_name": "KYLEENA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "levonorgestrel",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-12-13",
      "manufacturer": "Bayer Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "186786",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-01-09",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02459523"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00198",
      "drug_name": "GLYXAMBI",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "linagliptin, empagliflozin",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-12-15",
      "manufacturer": "Boehringer Ingelheim (Canada) Ltd./LtÃ©e.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "188534",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-01-09",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02459752",
        "02459760"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00199",
      "drug_name": "DURATOCIN",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "carbetocin",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-12-05",
      "manufacturer": "Ferring Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "190823",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-01-09",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00200",
      "drug_name": "DAKLINZA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "daclatasvir",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-11-09",
      "manufacturer": "Bristol-Myers Squibb Canada",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission - Confirmatory",
      "date_filed": null,
      "control_number": "189820",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-01-13",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00201",
      "drug_name": "GALEXOS",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "simeprevir",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-11-29",
      "manufacturer": "Janssen Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission - Confirmatory",
      "date_filed": null,
      "control_number": "190665",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-01-16",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00202",
      "drug_name": "HOLKIRA PAK",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ritonavir, paritaprevir, ombitasvir, dasabuvir",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-11-21",
      "manufacturer": "AbbVie Corporation",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "190518",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-01-16",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00203",
      "drug_name": "DOTAREM",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "gadoterate meglumine",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-11-26",
      "manufacturer": "Guerbet",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "186333",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-01-16",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02459329"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00204",
      "drug_name": "Gazyva",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "obinutuzumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-12-29",
      "manufacturer": "Hoffmann-La Roche Limited",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "191269",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-01-16",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00205",
      "drug_name": "Kevzara",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "sarilumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-01-12",
      "manufacturer": "Sanofi-Aventis Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "191745",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-01-19",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02460521",
        "02460548"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00206",
      "drug_name": "Fiasp",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Insulin aspart",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-01-06",
      "manufacturer": "Novo Nordisk Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "191494",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-01-23",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02460408 (vial)",
        "02460416 (Penfill cartridge)",
        "02460424 (pre-filled pen)"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00207",
      "drug_name": "Ilaris",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "canakinumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-01-06",
      "manufacturer": "Novartis Pharmaceuticals Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "195617",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-01-23",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02460351"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00208",
      "drug_name": "Mictoryl, Mictoryl Pediatric",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "propiverine hydrochloride",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-01-05",
      "manufacturer": "Duchesnay Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "188323",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-01-30",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02460262",
        "02460270",
        "02460289"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00209",
      "drug_name": "Afstyla",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "lonoctocog alfa  Recombinant Single-Chain Factor VIII (rVIII-SingleChain)",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-12-12",
      "manufacturer": "CSL Behring Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "190891",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-02-01",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02459531",
        "02459558",
        "02459566",
        "02459574",
        "02459582",
        "02459590",
        "02459604"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00210",
      "drug_name": "Orfadin",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Nitisinone",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-12-13",
      "manufacturer": "Swedish Orphan Biovitrum Ab (publ)",
      "prescription_status": null,
      "type_submission": "Priority New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "193226",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-02-15",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02459698",
        "02459701",
        "02459728",
        "02459736"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00212",
      "drug_name": "Rapivab",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Peramivir",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-01-05",
      "manufacturer": "Biocryst Pharmaceuticals Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "191280",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-03-08",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02460319"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00213",
      "drug_name": "Evicel",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Fibrin Sealant Kit",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-08-21",
      "manufacturer": "Omrix Biopharmaceuticals Ltd.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "178389",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-02-16",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02348497"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00214",
      "drug_name": "Obizur",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Antihemophilic Factor (Recombinant), Porcine Sequence",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-10-14",
      "manufacturer": "Baxalta Canada Corporation",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "177290",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-02-16",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02447401"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00333",
      "drug_name": "Ocrevus",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ocrelizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-02-14",
      "manufacturer": "Hoffmann-La Roche Limited",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "197969",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-02-26",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00215",
      "drug_name": "Cuvitru",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Immune Globulin Subcutaneous (Human), 20%",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-02-16",
      "manufacturer": "Baxalta Canada Corporation",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "190451",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-02-27",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02461692"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00216",
      "drug_name": "Imbruvica",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ibrutinib",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-02-01",
      "manufacturer": "Janssen Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "192718",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2016-02-29",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00217",
      "drug_name": "Replagal",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "agalsidase alfa",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-02-10",
      "manufacturer": "Shire Human Genetic Therapies, Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "188407",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-03-02",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02249057"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00218",
      "drug_name": "Lupron Depot",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "leuprolide acetate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-02-10",
      "manufacturer": "Abbvie Corporation",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "193372",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-03-07",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00219",
      "drug_name": "Oncaspar",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Pegaspargase",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-02-24",
      "manufacturer": "Baxalta Canada Corporation",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "189795",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-03-09",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02461900"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00220",
      "drug_name": "Enbrel",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "etanercept",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-03-14",
      "manufacturer": "Amgen Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "193787",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-04-04",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00221",
      "drug_name": "Vimpat",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "lacosamide",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-02-28",
      "manufacturer": "UCB Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "193732",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-04-04",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00222",
      "drug_name": "Rexulti",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "brexpiprazole",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-02-16",
      "manufacturer": "Otsuka Pharmaceutical Co. Ltd.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "192684",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-04-12",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02461749",
        "02461757",
        "02461765",
        "02461773",
        "02461781",
        "02461803"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00223",
      "drug_name": "Revolade",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "eltrombopag olamine",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-03-07",
      "manufacturer": "Novartis Pharmaceuticals Canada Inc",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "188969",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-04-12",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02461382"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00227",
      "drug_name": "Odefsey",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "emtricitabine, rilpivirine hydrochloride, tenofovir alafenamide fumarate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-02-10",
      "manufacturer": "Gilead Sciences Canada Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "192454",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-04-28",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02461463"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00224",
      "drug_name": "Berinert 500/ Berinert 1500",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "C1 Esterase Inhibitor (Human)",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-03-31",
      "manufacturer": "CSL Behring Canada, Inc.",
      "prescription_status": null,
      "type_submission": "Schedule D",
      "date_filed": null,
      "control_number": "197440",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-04-24",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00225",
      "drug_name": "Darzalex",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Daratumumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-04-13",
      "manufacturer": "Janssen Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "198647",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-04-24",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00226",
      "drug_name": "Erelzi",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "etanercept",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-04-06",
      "manufacturer": "Sandoz Canada Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "193864",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-04-24",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02462850, SC, SOL, 50 mg/mL SensoReady Pen",
        "02462869, SC, SOL, 50 mg/mL Prefilled Syringe",
        "02462877, SC, SOL, 25 mg/0.5 mL Prefilled Syringe"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00228",
      "drug_name": "Harvoni",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ledipasvir, sofosbuvir",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-02-13",
      "manufacturer": "Gilead Sciences Canada Inc",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "193140",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-05-01",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00229",
      "drug_name": "Primaquine",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "primaquine phosphate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-03-15",
      "manufacturer": "Sanofi-aventis Canada Inc",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "196046",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-05-01",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00230",
      "drug_name": "XOLAIR",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "omalizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-04-12",
      "manufacturer": "Novartis Pharmaceuticals Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "194542",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-05-24",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00240",
      "drug_name": "Tarceva",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "erlotinib (as erlotinib hydrochloride)",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-03-29",
      "manufacturer": "Hoffmann-La Roche Limited",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "194018",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-05-24",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00231",
      "drug_name": "alvimopan (*Entereg)",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "alvimopan",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Submmision cancelled",
      "decision_descr": null,
      "date_decision": "2017-03-29",
      "manufacturer": "Merck Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "189825",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-05-03",
      "footnotes": 0,
      "summary_title": "Summary of Cancellation for alvimopan (*Entereg)",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00232",
      "drug_name": "Portrazza",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Necitumumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-03-16",
      "manufacturer": "Eli Lilly Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "193689",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-05-09",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02462478"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00233",
      "drug_name": "Yervoy",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Ipilimumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-04-13",
      "manufacturer": "Bristol Myers Squibb Canada",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "202533",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-05-10",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02379384"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00234",
      "drug_name": "ACARIZAX",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Standardized Allergen Extract, House Dust Mites (D. farinae and D. pteronyssinus) Sublingual Tablet",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-05-04",
      "manufacturer": "ALK-Abello A/S",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "195186",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-05-18",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02463644"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00235",
      "drug_name": "Invokana",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Canagliflozin",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-04-13",
      "manufacturer": "Janssen Inc.",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "194762",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-05-18",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00236",
      "drug_name": "Kuvan",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "sapropterin dihydrochloride",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-10-18",
      "manufacturer": "Biomarin Pharmaceutical Inc",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "186959",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-05-18",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00237",
      "drug_name": "Brinavess",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "vernakalant hydrochloride",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-03-13",
      "manufacturer": "Cardiome UK Limited",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "190817",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-05-19",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02462400"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00238",
      "drug_name": "Cerdelga",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "eliglustat tartrate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-04-21",
      "manufacturer": "Sanofi Genzyme, A Division of Sanofi-aventis Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "183050",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-05-19",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02463261"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00239",
      "drug_name": "Tecentriq",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "atezolizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-04-12",
      "manufacturer": "Hoffman-La Roche Ltd.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "196843",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-05-23",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02462990"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00241",
      "drug_name": "Utrogestan",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "progesterone",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-04-05",
      "manufacturer": "Besins Healthcare S A",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "180004",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-05-24",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02462818"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00242",
      "drug_name": "Revolade",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "eltrombopag olamine",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-05-01",
      "manufacturer": "Novartis Pharmaceuticals Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "195798",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-05-26",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00243",
      "drug_name": "Otixal",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ciprofloxacin hydrochloride, fluocinolone acetonide",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-12-08",
      "manufacturer": "Pediapharm Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "189678",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-05-31",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02459655"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00250",
      "drug_name": "Orkambi",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ivacaftor, lumacaftor",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-04-18",
      "manufacturer": "Vertex Pharmaceuticals (Canada) Incorporated",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "198036",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-06-12",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02463040"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00244",
      "drug_name": "Viberzi",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "eluxadoline",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-01-26",
      "manufacturer": "Actavis Specialty Pharmaceuticals Co",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "190162",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-05-31",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02460890",
        "02460904"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00245",
      "drug_name": "Tivicay",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "dolutegravir sodium",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-02-03",
      "manufacturer": "ViiV Healthcare ULC",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "192462",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-05-31",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02461218",
        "02461226"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00246",
      "drug_name": "Vectibix",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Panitumumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-04-05",
      "manufacturer": "Amgen Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission",
      "date_filed": null,
      "control_number": "193962",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-05-31",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00247",
      "drug_name": "Kineret",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Anakinra",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-05-18",
      "manufacturer": "Swedish Orphan Biovitrum AB (publ); Med-Script Associates Ltd. is filing on behalf of the sponsor.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "195649",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-06-06",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "DIN 02245913"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00248",
      "drug_name": "LIXIANA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "edoxaban",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-11-04",
      "manufacturer": "Daiichi Sankyo Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "187363",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-06-12",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02458640",
        "02458659",
        "02458667"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00249",
      "drug_name": "Glatect",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "glatiramer acetate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-01-17",
      "manufacturer": "Pharmascience Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "191840",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-06-12",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "DIN 02460661"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00251",
      "drug_name": "PAZEO",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "olopatadine HCl",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-10-28",
      "manufacturer": "Alcon Canada Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "189463",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-06-12",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "DIN 02458551"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00252",
      "drug_name": "EYLEA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "aflibercept",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-05-19",
      "manufacturer": "Bayer Inc.",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission (SNDS), Response to Notice of Non-compliance (NON)",
      "date_filed": null,
      "control_number": "186851",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-06-21",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02415992"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00253",
      "drug_name": "Blincyto",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "blinatumomab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-04-13",
      "manufacturer": "Amgen Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission, Notice of Compliance with Conditions",
      "date_filed": null,
      "control_number": "197615",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-06-19",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02450282"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00254",
      "drug_name": "Fibryna",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "fibrinogen (Human)",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-06-07",
      "manufacturer": "Octapharma Pharmazeutika Produktionsges.m.b.H.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "195870",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-06-21",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02464616"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00255",
      "drug_name": "Victoza",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "liraglutide",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-06-15",
      "manufacturer": "Novo Nordisk Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission",
      "date_filed": null,
      "control_number": "196457",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-06-23",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00256",
      "drug_name": "OPDIVO",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "nivolumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-05-12",
      "manufacturer": "Bristol Myers Squibb Canada (BMS Canada)",
      "prescription_status": null,
      "type_submission": "Priority Supplemental New Drug Submission",
      "date_filed": null,
      "control_number": "199379",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-06-23",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00260",
      "drug_name": "Tepadina",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "thiotepa",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-03-29",
      "manufacturer": "Adienne SA",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "168816",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-07-06",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02462680",
        "02462702"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00257",
      "drug_name": "Nanostim Leadless Cardiac Pacemaker",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Application withdrawn",
      "decision_descr": null,
      "date_decision": "2016-11-22",
      "manufacturer": "St. Jude Medical, Cardiac Rhythm Management Division",
      "prescription_status": null,
      "type_submission": "",
      "date_filed": null,
      "control_number": "",
      "application_number": "252056",
      "application_type": "New device licence application",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": "Summary of Withdrawal - Nanostim Leadless Cardiac Pacemaker",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [],
      "bullet_list": null
    },
    {
      "link_id": "RDS00258",
      "drug_name": "Metvix",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "methyl aminolevulinate hydrochloride",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-04-03",
      "manufacturer": "Galderma Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "180975",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-07-06",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00259",
      "drug_name": "Adlyxine",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "lixisenatide",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-05-25",
      "manufacturer": "Sanofi-aventis Canada Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "193862",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-07-06",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02464349",
        "02464276",
        "02464284"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00261",
      "drug_name": "Ibrance",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "palbociclib",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-05-19",
      "manufacturer": "Pfizer Canada Inc",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "195948",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-07-06",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00262",
      "drug_name": "Lancora",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ivabradine hydrochloride",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-12-23",
      "manufacturer": "Servier Canada Inc",
      "prescription_status": null,
      "type_submission": "Lancora is available by prescription only.",
      "date_filed": null,
      "control_number": "166949",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-07-13",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02459973",
        "02459981"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00263",
      "drug_name": "Vyvanse",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "lisdexamfetamine dimesylate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-09-30",
      "manufacturer": "Shire Pharma Canada ULC",
      "prescription_status": null,
      "type_submission": "Vyvanse is available by prescription only.",
      "date_filed": null,
      "control_number": "181720",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-07-17",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02458071"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00264",
      "drug_name": "Procysbi",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "cysteamine bitartrate (also known as mercaptamine)",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-06-13",
      "manufacturer": "Horizon Pharma Ireland Ltd",
      "prescription_status": null,
      "type_submission": "Procysbi is available by prescription only.",
      "date_filed": null,
      "control_number": "191347",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-07-17",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02464705",
        "02464713"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00265",
      "drug_name": "Jentadueto",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "linagliptin/metformin hydrochloride",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Submmision cancelled",
      "decision_descr": null,
      "date_decision": "2017-05-02",
      "manufacturer": "Boehringer Ingelheim (Canada) Ltd/LtÃ©e",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "194067",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-07-18",
      "footnotes": 0,
      "summary_title": "Summary of Cancellation for linagliptin/metformin hydrochloride (Jentadueto)",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [],
      "bullet_list": null
    },
    {
      "link_id": "RDS00266",
      "drug_name": "Mekinist",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "trametinib",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-05-16",
      "manufacturer": "Novartis Pharmaceuticals Canada Inc.",
      "prescription_status": null,
      "type_submission": "Priority Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "199382",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-07-20",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00267",
      "drug_name": "Tafinlar",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "dabrafenib",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-05-16",
      "manufacturer": "Novartis Pharmaceuticals Canada Inc.",
      "prescription_status": null,
      "type_submission": "Priority Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "199381",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-07-20",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00268",
      "drug_name": "Spinraza",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "nusinersen sodium",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-06-29",
      "manufacturer": "Biogen Canada Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "200070",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-07-20",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02465663"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00269",
      "drug_name": "Keytruda",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Pembrolizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-07-12",
      "manufacturer": "Merck Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "198839",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-07-21",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "DIN not applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00270",
      "drug_name": "Defitelio",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "defibrotide sodium",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-07-10",
      "manufacturer": "Jazz Pharmaceuticals Ireland Limited",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "200808",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-08-02",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02465981"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00271",
      "drug_name": "Prolastin-C",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Alpha1-Proteinase Inhibitor (Human)",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-06-30",
      "manufacturer": "Grifols Therapeutics Inc.",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "205855",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-08-03",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00272",
      "drug_name": "Belbuca",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "buprenorphine hydrochloride buccal soluble film",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-06-21",
      "manufacturer": "Paladin Labs Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "196428",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-08-08",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02465221",
        "02465248",
        "02465256",
        "02465264",
        "02465272",
        "02465280",
        "02465299"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00273",
      "drug_name": "EMEND IV",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "fosaprepitant dimeglumine",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-07-26",
      "manufacturer": "Merck Canada Inc",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "197185",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-08-08",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00274",
      "drug_name": "Aggrastat",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "tirofiban HCl",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-07-12",
      "manufacturer": "Correvio (UK) Ltd",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "186324",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-08-10",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00275",
      "drug_name": "Entuzity",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Insulin injection, human biosynthetic",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-07-27",
      "manufacturer": "Eli Lilly Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "189076",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-08-10",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02466864"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00276",
      "drug_name": "Latuda",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "lurasidone hydrochloride",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-07-20",
      "manufacturer": "Sunovion Pharmaceuticals Canada Inc",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "197342",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-08-11",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00283",
      "drug_name": "Halaven",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "eribulin mesylate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-08-04",
      "manufacturer": "Eisai Limited",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "197739",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-08-31",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00277",
      "drug_name": "Fraxiparine / Fraxiparine Forte",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "nadroparin calcium",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-07-19",
      "manufacturer": "Aspen Pharmacare Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "195973",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-08-14",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00278",
      "drug_name": "Lipiodol Ultra Fluid",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ethiodized oil injection, house standard (std.)",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-07-13",
      "manufacturer": "Guerbet",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "196107",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-08-14",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "00386685"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00279",
      "drug_name": "Rydapt",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "midostaurin",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-07-21",
      "manufacturer": "Novartis Pharmaceuticals Canada Inc.",
      "prescription_status": null,
      "type_submission": "Priority New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "201101",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-08-21",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02466236"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00376",
      "drug_name": "Foquest",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "methylphenidate hydrochloride",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-12-06",
      "manufacturer": "Purdue Pharma",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "187330",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-01-23",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02470292",
        "02470306",
        "02470314",
        "02470322",
        "02470330",
        "02470349",
        "02470357"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00280",
      "drug_name": "Adcetris",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Brentuximab vedotin",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-07-20",
      "manufacturer": "Seattle Genetics Inc.",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "185779",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-08-22",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00281",
      "drug_name": "OCREVUS",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Ocrelizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-08-14",
      "manufacturer": "Hoffmann-La Roche Limited",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "198094",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-08-29",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02467224"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00282",
      "drug_name": "Flebogamma 5% / Flebogamma 10%",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Immune Globulin Intravenous (Human) 5% / Immune Globulin Intravenous (Human) 10%",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-08-17",
      "manufacturer": "Instituto Grifols, S.A.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "194291",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-08-29",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02467488, 50 mg/mL",
        "02467526, 100 mg/mL"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00284",
      "drug_name": "Tresiba",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Insulin degludec injection",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "",
      "decision_descr": null,
      "date_decision": "2017-08-25",
      "manufacturer": "Novo Nordisk Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "198124",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-09-13",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02467860 - 100 Unit/mL (Penfill)",
        "02467879 - 100 Unit/mL (FlexTouch)",
        "02467887 - 200 Unit/mL (FlexTouch)"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00285",
      "drug_name": "Xalkori",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "crizotinib",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-08-28",
      "manufacturer": "Pfizer Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "198322",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-09-28",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02384256"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00286",
      "drug_name": "Keytruda",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "pembrolizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-09-13",
      "manufacturer": "Merck Canada Inc",
      "prescription_status": null,
      "type_submission": "Supplementary New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "203157",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-10-04",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00297",
      "drug_name": "Maviret",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "glecaprevir, pibrentasvir",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-08-16",
      "manufacturer": "Abbvie Corporation",
      "prescription_status": null,
      "type_submission": "Priority New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "202233",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-11-28",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02467550"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00287",
      "drug_name": "Panzyga",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Immune Globulin Intravenous [Human]",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-10-04",
      "manufacturer": "Octapharma Pharmazeutika Produktionsges.m.b.H.",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission",
      "date_filed": null,
      "control_number": "201326",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-10-05",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00288",
      "drug_name": "Lenvima",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "lenvatinib mesylate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-09-13",
      "manufacturer": "Eisai Limited",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "197794",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-10-17",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02468220",
        "02468239"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00289",
      "drug_name": "Stivarga",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "regorafenib",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-08-29",
      "manufacturer": "Bayer Inc",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "199667",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-10-17",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00290",
      "drug_name": "Lanvis",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "thioguanine",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-09-21",
      "manufacturer": "Aspen Pharmacare Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "199259",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-10-18",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00291",
      "drug_name": "Galafold",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "migalastat hydrochloride",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-09-05",
      "manufacturer": "Amicus Therapeutics UK Ltd",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "196956",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-10-27",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02468042"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00292",
      "drug_name": "Iron Dextran Injection USP",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Iron Dextran Injection USP",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Submmision cancelled",
      "decision_descr": null,
      "date_decision": "2017-06-08",
      "manufacturer": "Sandoz Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "189897",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-10-30",
      "footnotes": 0,
      "summary_title": "Summary of Cancellation : Iron Dextan Injection USP",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [],
      "bullet_list": null
    },
    {
      "link_id": "RDS00293",
      "drug_name": "Shingrix",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Herpes Zoster vaccine (non-live recombinant, AS01<sub>B</sub> adjuvanted)",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-10-13",
      "manufacturer": "GlaxoSmithKline Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "200244",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-11-01",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02468425"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00294",
      "drug_name": "Mifegymiso",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Mifepristone and misoprostol",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-11-07",
      "manufacturer": "Linepharma International Limited",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "200856",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-11-06",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02444038"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00295",
      "drug_name": "Haegarda",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "C1 Esterase Inhibitor (Human) or CSL830",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-09-01",
      "manufacturer": "CSL Behring Canada, Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "198308",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-11-06",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02468069",
        "02468077"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00296",
      "drug_name": "Trumenba",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Meningococcal group B vaccine [Bivalent recombinant lipoprotein (rLP2086)]",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-10-05",
      "manufacturer": "Pfizer Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "195550",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-11-27",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02468751"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00298",
      "drug_name": "Vosevi",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "sofosbuvir, velpatasvir, voxilaprevir",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "",
      "decision_descr": null,
      "date_decision": "2017-08-16",
      "manufacturer": "Gilead Sciences Canada Inc",
      "prescription_status": null,
      "type_submission": "Priority New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "202324",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-11-28",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02467542"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00299",
      "drug_name": "Epclusa",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "sofosbuvir, velpatasvir",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-09-14",
      "manufacturer": "Gilead Sciences Canada Inc",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "199753",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-11-28",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00300",
      "drug_name": "NiaStase RT",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Eptacog Alfa (activated)",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-11-10",
      "manufacturer": "Novo Nordisk Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "200866",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-11-30",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00301",
      "drug_name": "Anthrasil",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Anthrax Immune Globulin (Human)",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-11-06",
      "manufacturer": "Emergent BioSolutions Canada Inc.",
      "prescription_status": null,
      "type_submission": "Extraordinary Use New Drug Submission (EUNDS)",
      "date_filed": null,
      "control_number": "200446",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-11-30",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02469588"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00302",
      "drug_name": "Lucentis",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Ranibizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-11-03",
      "manufacturer": "Novartis Pharmaceuticals Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission",
      "date_filed": null,
      "control_number": "201272",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-12-05",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00303",
      "drug_name": "Actemra",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "tocilizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-10-27",
      "manufacturer": "Hoffmann-La Roche Limited",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "204251",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-12-11",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00304",
      "drug_name": "Imfinzi",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Durvalumab for injection",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-11-03",
      "manufacturer": "AstraZeneca Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "202953",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-12-13",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02468816"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00305",
      "drug_name": "Renflexis",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Infliximab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-12-01",
      "manufacturer": "Samsung Bioepis Co., Ltd.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "188114",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-12-13",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02470373"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00306",
      "drug_name": "Triamcinolone Hexacetonide Injectable Suspension",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Triamcinolone Hexacetonide",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-12-12",
      "manufacturer": "Medexus Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "201546",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-12-14",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02470632"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00307",
      "drug_name": "Xeljanz XR",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "tofacitinib",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-12-12",
      "manufacturer": "Pfizer Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "200033",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-12-14",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02470608"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00382",
      "drug_name": "Opdivo",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "nivolumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-07-06",
      "manufacturer": "Bristol-Myers Squibb Canada",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "212067",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-07-06",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00308",
      "drug_name": "Tremfya",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Guselkumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-11-10",
      "manufacturer": "Janssen Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "200590",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-12-14",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02469758"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00309",
      "drug_name": "Dupixent",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Dupilumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-11-30",
      "manufacturer": "Sanofi-Aventis Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "201285",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-12-18",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02470365"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00310",
      "drug_name": "Rebinyn",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Coagulation Factor IX (Recombinant), Pegylated",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-11-29",
      "manufacturer": "Novo Nordisk Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "201114",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-12-18",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02470187, IV, PWSO, 500 IU / vial",
        "02470268, IV, PWSO, 1000 IU / vial",
        "02470276, IV, PWSO, 2000 IU / vial"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00311",
      "drug_name": "Plivensia",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "sirukumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Submission cancelled",
      "decision_descr": null,
      "date_decision": "2017-10-19",
      "manufacturer": "GlaxoSmithKline Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance )",
      "date_filed": null,
      "control_number": "205568",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-12-18",
      "footnotes": 0,
      "summary_title": "Summary of Cancellation : sirukumab - PLIVENSIA",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00312",
      "drug_name": "Victoza",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Liraglutide",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-11-17",
      "manufacturer": "Novo Nordisk",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "200821",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-12-20",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00316",
      "drug_name": "Trulicity",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "dulaglutide",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-12-22",
      "manufacturer": "Eli Lilly Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission",
      "date_filed": null,
      "control_number": "201964",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-01-15",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00313",
      "drug_name": "ADMELOG",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Insulin lispro",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-11-16",
      "manufacturer": "Sanofi-Aventis Canada Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "200792",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-12-27",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02469901",
        "02469898",
        "02469871"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00314",
      "drug_name": "LARTRUVO",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "olaratumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-11-23",
      "manufacturer": "Eli Lilly Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "203478",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-12-27",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02469227"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00315",
      "drug_name": "Kanuma",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Sebelipase alfa",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-12-15",
      "manufacturer": "Alexion Pharma GmbH",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "204085",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-01-11",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02469596"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00317",
      "drug_name": "Ozempic",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "semaglutide injection",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-01-04",
      "manufacturer": "Novo Nordisk Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "202059",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-01-15",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02471469 Fixed Dose Pen (dose of 1 mg)",
        "02471477 Dual Dose Pen (doses of 0.25 mg or 0.5 mg)"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00318",
      "drug_name": "DaTscan",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Ioflupane (<sup>123</sup>I)",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-12-07",
      "manufacturer": "GE Healthcare Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "201481",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-01-15",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00322",
      "drug_name": "BAVENCIO",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Avelumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-12-18",
      "manufacturer": "EMD Serono",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "204052",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-01-23",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02469723"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00319",
      "drug_name": "Dysport Therapeutic",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "abobotulinumtoxinA",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-12-21",
      "manufacturer": "Ipsen Biopharm Limited",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission",
      "date_filed": null,
      "control_number": "202245",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-01-18",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00320",
      "drug_name": "Xiaflex",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "collagenase clostridium histolyticum",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-01-02",
      "manufacturer": "Endo Ventures Ltd.",
      "prescription_status": null,
      "type_submission": "Supplementary New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "202488",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-01-19",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00321",
      "drug_name": "OPDIVO",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Nivolumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-11-10",
      "manufacturer": "Bristol-Myers Squibb Canada Co",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission",
      "date_filed": null,
      "control_number": "203286",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-01-23",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00323",
      "drug_name": "Keytruda",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Pembrolizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-09-05",
      "manufacturer": "Merck Canada",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission",
      "date_filed": null,
      "control_number": "201200",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-02-05",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00324",
      "drug_name": "Akynzeo",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "palonosetron hydrochloride, netupitant",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-09-28",
      "manufacturer": "Purdue Pharma",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "196495",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-02-05",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02468735"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00325",
      "drug_name": "Lonsurf",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "trifluridine, tipiracil hydrochloride",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-01-25",
      "manufacturer": "Taiho Pharma Canada, Inc.",
      "prescription_status": null,
      "type_submission": "Priority New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "205852",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-02-07",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02472104",
        "02472112"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00327",
      "drug_name": "Baca Respiclick",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "salbutamol sulfate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-11-01",
      "manufacturer": "Teva Canada Limited",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "189577",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-02-07",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02469359"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00328",
      "drug_name": "Accel-sevelamer",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "sevelamer carbonate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-10-11",
      "manufacturer": "Accel Pharma Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "189932",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-02-07",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02461501"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00329",
      "drug_name": "Mavenclad",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "cladribine",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-11-30",
      "manufacturer": "Emd Serono A Division Of Emd Inc Canada",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "200943",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-02-07",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02470179"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00330",
      "drug_name": "Afinitor Disperz",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "everolimus",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-11-17",
      "manufacturer": "Novartis Pharmaceuticals Canada Inc",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "200814",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-02-07",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00331",
      "drug_name": "Somatuline Autogel",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Lanreotide acetate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-02-02",
      "manufacturer": "Ipsen Biopharm Limited",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "203094",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-02-15",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00332",
      "drug_name": "Prolia",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Denosumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-02-13",
      "manufacturer": "Amgen Canada, Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "203717",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-02-26",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00334",
      "drug_name": "Cutaquig",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Immunoglobulin (human) subcutaneous",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-02-15",
      "manufacturer": "Octapharma Pharmazeutika Produktionsges.m.b.H.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "202924",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-03-01",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02472996",
        "02473003",
        "02473011",
        "02473038",
        "02473046",
        "02473054"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00335",
      "drug_name": "Zytiga",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "abiraterone acetate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-02-13",
      "manufacturer": "Janssen Inc",
      "prescription_status": null,
      "type_submission": "Priority Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "207915",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-03-01",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00336",
      "drug_name": "Opdivo",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Nivolumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Cancelled by sponsor",
      "decision_descr": null,
      "date_decision": "2018-01-19",
      "manufacturer": "Bristol-MyersÂ Squibb Canada Co.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "203593",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-03-06",
      "footnotes": 0,
      "summary_title": "Summary of Cancellation for Opdivo",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [],
      "bullet_list": null
    },
    {
      "link_id": "RDS00337",
      "drug_name": "Fasenra",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Benralizumab injection",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-02-22",
      "manufacturer": "AstraZeneca Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "204008",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-02-22",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02473232"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00338",
      "drug_name": "Ixiaro",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Japanese Encephalitis Vaccine, (inactivated, adsorbed)",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-03-02",
      "manufacturer": "Valneva Austria GmbH",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "203520",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-02-28",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00339",
      "drug_name": "Auro-Cefixime",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Cefixime",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-10-11",
      "manufacturer": "Auro Pharma Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "189720",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-03-16",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "DIN 02468689"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00340",
      "drug_name": "Sitavig",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "acyclovir",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-11-27",
      "manufacturer": "Cipher Pharmaceuticals Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "189933",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-03-16",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02470098"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00341",
      "drug_name": "Xiidra",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "lifitegrast",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-12-22",
      "manufacturer": "Shire Pharma Canada ULC",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "199810",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-03-20",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02471027"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00342",
      "drug_name": "Prevymis",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "letermovir",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-11-01",
      "manufacturer": "Merck Canada Inc",
      "prescription_status": null,
      "type_submission": "Priority New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "204165",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-03-20",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02469367",
        "02469375",
        "02469383",
        "02469405"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00343",
      "drug_name": "Cuvposa",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "glycopyrrolate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-10-30",
      "manufacturer": "Pediapharm Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "197038",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-03-20",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02469332"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00344",
      "drug_name": "Afluria Tetra",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Quadrivalent Inactivated Influenza Vaccine (Split Virion)",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-02-22",
      "manufacturer": "Seqirus Pty Ltd",
      "prescription_status": null,
      "type_submission": "New Drug Submission (NDS)",
      "date_filed": null,
      "control_number": "203436",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-03-20",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02473283",
        "02473313"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00345",
      "drug_name": "Blincyto",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "blinatumomab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-03-05",
      "manufacturer": "Amgen Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "204154",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-03-22",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00346",
      "drug_name": "ORENCIA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Abatacept",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-03-15",
      "manufacturer": "Bristol-Myers Squibb Canada",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "204313",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-03-28",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00347",
      "drug_name": "Dysport Therapeutic",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "AbobotulinumtoxinA",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-03-09",
      "manufacturer": "Ipsen Biopharm Limited",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "204299",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-04-04",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00348",
      "drug_name": "ADDYI",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "flibanserin",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-02-27",
      "manufacturer": "Sprout Pharmaceuticals Inc",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "189352",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-04-09",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02473550"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00349",
      "drug_name": "Besponsa",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Inotuzumab ozogamicin",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-03-15",
      "manufacturer": "Pfizer Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "204077",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-04-09",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02473909"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00350",
      "drug_name": "Simponi I.V.",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "golimumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-04-05",
      "manufacturer": "Janssen Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "205724",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-04-19",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00351",
      "drug_name": "Jaydess",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "levonorgestrel",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-03-14",
      "manufacturer": "Bayer Inc",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "204355",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-04-23",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00352",
      "drug_name": "Kisqali",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ribociclib succinate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-03-02",
      "manufacturer": "Novartis Pharmaceuticals Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "203884",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-04-24",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02473569"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00353",
      "drug_name": "Rekovelle",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "follitropin delta",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-03-22",
      "manufacturer": "Ferring Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "188743",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-04-24",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02474077, 72 mcg / 2.16 mL",
        "02474085, 36 mcg / 1.08 mL",
        "02474093, 12 mcg / 0.36 mL"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00354",
      "drug_name": "Tecentriq",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "atezolizumab injection",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-04-06",
      "manufacturer": "Hoffmann-La Roche Limited",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "205038",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-04-25",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00355",
      "drug_name": "TALTZ",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Ixekizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-03-29",
      "manufacturer": "Eli Lilly Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplementary New Drug Submission",
      "date_filed": null,
      "control_number": "204690",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-04-26",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00356",
      "drug_name": "Rituxan SC",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Rituximab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-03-21",
      "manufacturer": "Hoffman-La Roche Limited",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "204718",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-04-27",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02473976"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00357",
      "drug_name": "Lapelga",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Pegfilgrastim injection",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-04-05",
      "manufacturer": "Apotex Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "204841",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-04-30",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02474565"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00383",
      "drug_name": "HIZENTRA",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Immune globulin (Human)",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-07-12",
      "manufacturer": "CSL Behring",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "208033",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-07-25",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00358",
      "drug_name": "Norditropin NordiFlex",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "somatotropin",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-04-25",
      "manufacturer": "Novo Nordisk Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplementary New Drug Submission (SNDS)",
      "date_filed": null,
      "control_number": "205985",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-05-02",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00359",
      "drug_name": "Xultophy",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "insulin degludec + liraglutide",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-04-11",
      "manufacturer": "Novo Nordisk Canada Inc.",
      "prescription_status": null,
      "type_submission": "NDS",
      "date_filed": null,
      "control_number": "194513",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-05-09",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02474875"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00360",
      "drug_name": "Glyxambi",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "linagliptin, empagliflozin",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-04-20",
      "manufacturer": "Boehringer Ingelheim (Canada) Ltd",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "204589",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-05-11",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00361",
      "drug_name": "Opdivo",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Nivolumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-03-23",
      "manufacturer": "Bristol Myers Squibb Canada",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission",
      "date_filed": null,
      "control_number": "206974",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-05-16",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00362",
      "drug_name": "Bavencio",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "avelumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-05-04",
      "manufacturer": "EMD Serono, A Division of EMD Inc., Canada",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "208742",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-05-16",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02469723"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00363",
      "drug_name": "Dysport Aesthetic",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "AbobotulinumtoxinA for injection",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-04-24",
      "manufacturer": "Ipsen Biopharm Limited",
      "prescription_status": null,
      "type_submission": "Supplement New Drug Submission",
      "date_filed": null,
      "control_number": "206921",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-05-22",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00364",
      "drug_name": "Alphanate",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Antihemophilic Factor/von Willebrand Factor Complex (Human)",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-05-11",
      "manufacturer": "Grifols Biologicals LLC",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "194071",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-05-23",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02475561",
        "02475588",
        "02575596",
        "02475618",
        "02475626"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00365",
      "drug_name": "Siliq",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "brodalumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-03-06",
      "manufacturer": "Valeant Canada LP/ Valeant Canada S.E.C.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "195317",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-05-31",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02473623"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00366",
      "drug_name": "Imfinzi",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "durvalumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-05-04",
      "manufacturer": "AstraZeneca Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission*",
      "date_filed": null,
      "control_number": "208834",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-05-31",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00367",
      "drug_name": "Xgeva",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "denosumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-04-04",
      "manufacturer": "Amgen Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission",
      "date_filed": null,
      "control_number": "205235",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-05-31",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00368",
      "drug_name": "Mvasi",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Bevacizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-04-30",
      "manufacturer": "Amgen Canada Inc.",
      "prescription_status": null,
      "type_submission": "Type of Submission",
      "date_filed": null,
      "control_number": "201427",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-06-05",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02470748",
        "02470756"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00369",
      "drug_name": "Latuda",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "lurasidone hydrochloride",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-04-19",
      "manufacturer": "Sunovion Pharmaceuticals Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "205325",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-06-19",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00370",
      "drug_name": "lorcaserin hydrochloride (*Belviq)",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "lorcaserin hydrochloride",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Cancelled by sponsor",
      "decision_descr": null,
      "date_decision": "2018-02-02",
      "manufacturer": "Eisai Limited.",
      "prescription_status": null,
      "type_submission": "New Drug Submission (New Active Substance)",
      "date_filed": null,
      "control_number": "198689",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-06-19",
      "footnotes": 0,
      "summary_title": "Summary of Cancellation: lorcaserin hydrochloride (*Belviq)",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [],
      "bullet_list": null
    },
    {
      "link_id": "RDS00371",
      "drug_name": "Imbruvica",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "ibrutinib",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-10-25",
      "manufacturer": "Janssen Inc.",
      "prescription_status": null,
      "type_submission": "Priority Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "204436",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-07-04",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00372",
      "drug_name": "Segluromet",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "metformin hydrochloride, ertugliflozin pidolate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-05-30",
      "manufacturer": "Merck Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "201005",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-07-04",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02476215",
        "02476223",
        "02476231",
        "02476258"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00373",
      "drug_name": "Steglujan",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "sitagliptin phosphate monohydrate, ertugliflozin pidolate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-05-22",
      "manufacturer": "Merck Canada Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "201006",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-05-30",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02475901",
        "02475928"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00374",
      "drug_name": "Arbesda Respiclick",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "fluticasone propionate, salmeterol xinafoate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-04-06",
      "manufacturer": "Teva Canada Limited",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "197974",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-05-16",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02474611",
        "02474638",
        "02474646"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00375",
      "drug_name": "Probuphine",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "buprenorphine hydrochloride",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-04-18",
      "manufacturer": "Knight Therapeutics Inc.",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "204746",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-05-16",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "02474921"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00377",
      "drug_name": "Tafinlar",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Dabrafenib mesylate",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-05-18",
      "manufacturer": "Novartis Pharmaceuticals Canada Inc.",
      "prescription_status": null,
      "type_submission": "Priority Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "210753",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-07-11",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00378",
      "drug_name": "Mekinist",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "trametinib dimethyl sulfoxide",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-05-18",
      "manufacturer": "Novartis Pharmaceuticals Canada Inc.",
      "prescription_status": null,
      "type_submission": "Priority Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "210760",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-07-11",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00379",
      "drug_name": "Ikervis",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "cyclosporin",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Rejected",
      "decision_descr": null,
      "date_decision": "2018-04-13",
      "manufacturer": "Santen Incorporated",
      "prescription_status": null,
      "type_submission": "New Drug Submission",
      "date_filed": null,
      "control_number": "194580",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-05-15",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "Not Applicable"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00380",
      "drug_name": "Avastin",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Bevacizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-06-06",
      "manufacturer": "Hoffmann-La Roche Limited",
      "prescription_status": null,
      "type_submission": "Supplemental New Drug Submission",
      "date_filed": null,
      "control_number": "207259",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-06-01",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS00381",
      "drug_name": "AVASTIN",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Bevacizumab",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Cancelled by sponsor",
      "decision_descr": null,
      "date_decision": "2018-05-23",
      "manufacturer": "Hoffman La-Roche Limited",
      "prescription_status": null,
      "type_submission": "SNDS-C",
      "date_filed": null,
      "control_number": "",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2017-07-04",
      "footnotes": 0,
      "summary_title": "Summary of Cancellation for AVASTIN (Control number 207217)",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [],
      "bullet_list": null
    },
    {
      "link_id": "RDS00384",
      "drug_name": "Tresiba",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "Insulin Degludec",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-07-17",
      "manufacturer": "Novo Nordisk Canada Inc.",
      "prescription_status": null,
      "type_submission": "Supplement to a New Drug Submission",
      "date_filed": null,
      "control_number": "208917",
      "application_number": "",
      "application_type": "",
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": "2018-07-17",
      "footnotes": 0,
      "summary_title": "",
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": false,
      "din_list": [
        "N/A"
      ],
      "bullet_list": null
    },
    {
      "link_id": "RDS10001",
      "drug_name": "Absorb GT1 Bioressorbable Vascular Scaffold System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-06-21",
      "manufacturer": "Abbott Vascular",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "238568",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10002",
      "drug_name": "Accent MRI",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-12-08",
      "manufacturer": "St. Jude Medical, Cardiac Rhythm Management Division",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "235925",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10003",
      "drug_name": "Acuity X4",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-02-03",
      "manufacturer": "Cardiac Pacemakers Incorporated",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "245269",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10004",
      "drug_name": "Amplatzer Cardiac Plug",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-03-18",
      "manufacturer": "AGA Medical Corporation",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "222870",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10005",
      "drug_name": "Armada 18 PTA Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-11-27",
      "manufacturer": "ABBOTT VASCULAR",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "241841",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10006",
      "drug_name": "Barricade Coil System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-02-26",
      "manufacturer": "BLOCKADE MEDICAL LLC",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "239401",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10007",
      "drug_name": "Biodesign Rectopexy Graft",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-05-19",
      "manufacturer": "Cook Biotech Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "252770",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10008",
      "drug_name": "Bioplex 2200 System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-06-25",
      "manufacturer": "BIO-RAD LABORATORIES CLINICAL DIAGNOSTICS GROUP",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "227609",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10009",
      "drug_name": "Biostrip Resorbable Collagen",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-11-17",
      "manufacturer": "NOVABONE PRODUCTS LLC",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "240495",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10010",
      "drug_name": "Cerasorb Ortho Foam",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-05-08",
      "manufacturer": "CURASAN AG",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "233699",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10011",
      "drug_name": "Collagen Dental Membrane - Conformable porcine peritoneum",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-11-06",
      "manufacturer": "COLLAGEN MATRIX, INC.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "239496",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10012",
      "drug_name": "Collagen Membrane",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-05-13",
      "manufacturer": "Matricel GMBH",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "232797",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10016",
      "drug_name": "Edwards Sapien 3 Transcatheter Heart Valve Kits",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-07-25",
      "manufacturer": "Edwards Lifesciences LLC",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "246453",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10013",
      "drug_name": "Cor-Knot",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-07-27",
      "manufacturer": "LSI SOLUTIONS",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "235320",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10014",
      "drug_name": "DA VINCI XI Surgical System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-07-27",
      "manufacturer": "Intuitive Surgical Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "238405",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10015",
      "drug_name": "Duragen Secure Dural Regeneration Matrix",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-02-05",
      "manufacturer": "Integra Lifesciences Corp.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "232811",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10017",
      "drug_name": "Emblem S-ICD System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-08-05",
      "manufacturer": "Cardiac Pacemakers Incorporated",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "237883",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10018",
      "drug_name": "NC Emerge PTCA Dilatation Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-07-27",
      "manufacturer": "Boston Scientific Corporation",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "249995",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10019",
      "drug_name": "Epyra",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-04-22",
      "manufacturer": "Biotronik SE & CO. KG",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "230697",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10020",
      "drug_name": "Freedom Spinal Cord Stimulator System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-07-27",
      "manufacturer": "Stimwave Technologies Incorporated",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "252146",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10021",
      "drug_name": "Firmap Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-02-11",
      "manufacturer": "Abbott Electrophysiology",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "244385",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10022",
      "drug_name": "Geenius",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-10-15",
      "manufacturer": "BIO-RAD",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "242690",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10023",
      "drug_name": "Gore Acuseal Vascular Graft",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-03-29",
      "manufacturer": "W.L. Gore & Associates Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "245505",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10024",
      "drug_name": "Guidoss Collagen Membrane Matrix",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-04-22",
      "manufacturer": "NIBEC CO., LTD.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "236261",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10025",
      "drug_name": "Integra Flowable Wound Matrix",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-03-11",
      "manufacturer": "INTEGRA LIFESCIENCES CORPORATION DBA INTEGRA NEUROSCIENCES",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "231432",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10026",
      "drug_name": "Intellamap Orion High Resolution Mapping Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-01-12",
      "manufacturer": "Rhythmia Medical, Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "241965",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10027",
      "drug_name": "Intercept Blood System for Plasma",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-05-17",
      "manufacturer": "Cerus Corporation",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "223509",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10028",
      "drug_name": "LEO+/LEO+ BABY",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-07-27",
      "manufacturer": "Balt Extrusion",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "243492",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10031",
      "drug_name": "Lyoplant Onlay",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-11-09",
      "manufacturer": "AESCULAP AG",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "237125",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10029",
      "drug_name": "Lifevest Model 4000",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-11-04",
      "manufacturer": "Zoll Manufacturing Corporation",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "228865",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10030",
      "drug_name": "Lutonix 035 Drug Coated Balloon PTA Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-11-09",
      "manufacturer": "LUTONIX, INC.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "225012",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10032",
      "drug_name": "Osteoselect DBM Putty",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-07-20",
      "manufacturer": "BACTERIN INTERNATIONAL, INC.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "234320",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10033",
      "drug_name": "Mozec NC RX PTCA Balloon Dilatation Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-02-18",
      "manufacturer": "MERIL LIFE SCIENCES PVT., LTD.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "246679",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10034",
      "drug_name": "MYNXGRIP Vascular Closure Device",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-08-10",
      "manufacturer": "Cardinal Health",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "236229",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10035",
      "drug_name": "Nudel",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-11-16",
      "manufacturer": "NuMED CANADA INC.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "240954",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10139",
      "drug_name": "Precision Montage MRI Spinal Cord Stimulator System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-04-25",
      "manufacturer": "Boston Scientific Neuromodulation Corporation",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "254468",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10036",
      "drug_name": "NuOss Anorganic Bovine Bone",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-05-08",
      "manufacturer": "COLLAGEN MATRIX, INC.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "233103",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10037",
      "drug_name": "OCS-B OsteoConductive Substitute-Bovine",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-05-08",
      "manufacturer": "Nibec CO., LTD.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "233342",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10046",
      "drug_name": "Perceval S Heart Valve",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-06-16",
      "manufacturer": "SORIN GROUP CANADA INC., MITROFLOW DIVISION",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "227782",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10038",
      "drug_name": "Optium DBM Putty",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-07-14",
      "manufacturer": "LIFENET HEALTH",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "232483",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10039",
      "drug_name": "Optomonitor System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-07-14",
      "manufacturer": "OPSENS, INC.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "236662",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10040",
      "drug_name": "OptoWire Deux Pressure Guidewire",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-06-17",
      "manufacturer": "Opsens, Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "248360",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10041",
      "drug_name": "OSSIX PLUS",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-08-05",
      "manufacturer": "Datum Dental Ltd.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "237921",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10042",
      "drug_name": "Osteoselect DBM Putty",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-07-20",
      "manufacturer": "BACTERIN INTERNATIONAL, INC.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "234320",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10043",
      "drug_name": "Pantera LUX Paclitaxel Releasing PTCA Balloon Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-07-09",
      "manufacturer": "BIOTRONIK AG",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "199400",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10044",
      "drug_name": "Penumbra Occlusion Device (POD)",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-05-13",
      "manufacturer": "Penumbra Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "234141",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10045",
      "drug_name": "Penumbra Smart Coil",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-10-29",
      "manufacturer": "Penumbra Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "235128",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10047",
      "drug_name": "Platinium Implantable Defibrillators",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-06-22",
      "manufacturer": "Sorin Group Italia S.R.L. (Sorin Crm)",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "246761",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10048",
      "drug_name": "Porcine Anorganic Bone Mineral",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-04-06",
      "manufacturer": "Collagen Matrix, Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "243969",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10049",
      "drug_name": "Precision Novi Spinal Cord Stimulator System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-10-20",
      "manufacturer": "Boston Scientific Neuromodulation Corporation",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "237922",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10051",
      "drug_name": "Prodigy Neurostimulation System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-04-21",
      "manufacturer": "St. Jude Medical",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "227632",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10052",
      "drug_name": "ProTrack RF Anchor Kit",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-07-14",
      "manufacturer": "BAYLIS MEDICAL COMPANY INC.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "237787",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10053",
      "drug_name": "Q50 Plus and Aria Stent Graft Balloon Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-11-25",
      "manufacturer": "QXMEDICAL, LLC",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "241352",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10054",
      "drug_name": "Rebel Monorail PtCr Coronary Stent System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-04-10",
      "manufacturer": "BOSTON SCIENTIFIC CORPORATION",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "234772",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10057",
      "drug_name": "SENSATION PLUS",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-03-02",
      "manufacturer": "DATASCOPE CORP.",
      "prescription_status": null,
      "type_submission": "New",
      "date_filed": null,
      "control_number": "241296",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10055",
      "drug_name": "RegenePro",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-06-05",
      "manufacturer": "SYNTACOLL GMBH",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "233140",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10056",
      "drug_name": "ReVive SE Thrombectomy Device",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-05-13",
      "manufacturer": "MEDOS International SARL",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "244855",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10058",
      "drug_name": "Specify Surescan MRI Lead Kit",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-07-12",
      "manufacturer": "Medtronic Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "249589",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10059",
      "drug_name": "SW033 software",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-11-20",
      "manufacturer": "Medtronic Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "235866",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10060",
      "drug_name": "Symbotex Composite Mesh Flat Sheet",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-01-12",
      "manufacturer": "Sofradim Production",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "239616",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10061",
      "drug_name": "Symbotex Composite Mesh with Flap",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-01-12",
      "manufacturer": "Sofradim Production",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "239614",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10062",
      "drug_name": "Symbotex Composite Mesh Flat Sheet with Sutures",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-01-12",
      "manufacturer": "Sofradim Production",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "239615",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10063",
      "drug_name": "SYNTHECEL - Dura Repair and Dura Onlay",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-11-09",
      "manufacturer": "Synthes (Canada) Ltd.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "233811",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10064",
      "drug_name": "Syphilis (Donor Screening for Transplantation)",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-10-16",
      "manufacturer": "ROCHE DIAGNOSTICS GMBH",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "236129",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10068",
      "drug_name": "Ultraverse 035 PTA Dilatation Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-05-24",
      "manufacturer": "Bard Peripheral Vascular, Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "241027",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10065",
      "drug_name": "Threader Micro-Dilatation Catheters",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-07-27",
      "manufacturer": "Boston Scientific Corporation",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "247351",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10066",
      "drug_name": "Tendril MRI (Magnetic Resonance Imaging)",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-12-08",
      "manufacturer": "St. Jude Medical, Cardiac Rhythm Management Division",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "235926",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10067",
      "drug_name": "Thoraflex Hybrid - Plexus 4 Hybrid Stent Device",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-04-06",
      "manufacturer": "Vascutek Limited a Terumo Company",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "238193",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10069",
      "drug_name": "V8 Balloon Aortic Valvuloplasty Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-12-04",
      "manufacturer": "Intervalve Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "241608",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10070",
      "drug_name": "Vercise PC Deep Brain Stimulation (DBS) System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-04-15",
      "manufacturer": "Boston Scientific Neuromodulation Corporation",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "245396",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10073",
      "drug_name": "Zenapro",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-08-05",
      "manufacturer": "Cook Biotech Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "23589",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10071",
      "drug_name": "Watchman Left Atrial Appendage Closure Device with Delivery System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-01-19",
      "manufacturer": "Boston Scientific Corporation",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "240876",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10072",
      "drug_name": "Xpert Pro Peripheral Self-Expanding Stent System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-02-25",
      "manufacturer": "Abbott Vascular",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "240445",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10074",
      "drug_name": "Biodesign Otologic Repair Graft",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-09-15",
      "manufacturer": "Cook Biotech Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "252820",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10075",
      "drug_name": "cobas WNV",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-01-15",
      "manufacturer": "ROCHE DIAGNOSTICS GMBH",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "237510",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10076",
      "drug_name": "IPERIA 5/7 (ProMRI) ICD Family",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-08-15",
      "manufacturer": "BIOTRONIK SE &amp; CO. KG",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "247030",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10077",
      "drug_name": "cobas HCV",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-07-12",
      "manufacturer": "Roche Diagnostics GmbH",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "248671",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10080",
      "drug_name": "VIROTROL IV",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-08-15",
      "manufacturer": "Bio-Rad Laboratories",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "254020",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10081",
      "drug_name": "Solarice Rapid Exchange Balloon Dilatation Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-09-12",
      "manufacturer": "MEDTRONIC INC.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "248745",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10082",
      "drug_name": "cobas 6800/8800 Systems",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2015-10-02",
      "manufacturer": "ROCHE DIAGNOSTICS GMBH",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "237508",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10083",
      "drug_name": "Prokera",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-09-19",
      "manufacturer": "BIOTISSUE, INC.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "246288",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10084",
      "drug_name": "ITREVIA 5/7 ICD Family",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-08-12",
      "manufacturer": "BIOTRONIK SE &amp; CO. KG",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "247036",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10085",
      "drug_name": "Sentus Implantable Coronary Sinus Leads",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-09-16",
      "manufacturer": "BIOTRONIK SE &amp; CO. KG",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "246848",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10086",
      "drug_name": "Prokera Slim",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-09-19",
      "manufacturer": "BIOTISSUE, INC.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "246287",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10087",
      "drug_name": "Vitala Porcine Derived Collagen Membrane",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-09-09",
      "manufacturer": "OSTEOGENICS BIOMEDICAL, INC.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "251364",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10088",
      "drug_name": "SYMBIOS Collagen Membrane pre-hydrated-Conformable II Bovine Pericardium",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-10-27",
      "manufacturer": "Collagen Matrix, Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "253211",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10089",
      "drug_name": "Edwards INTUITY Elite",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-10-13",
      "manufacturer": "Edwards Lifesciences LLC",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "248741",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10090",
      "drug_name": "Reprocessed Diagnostic Electrophysiology Catheters",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-09-30",
      "manufacturer": "Stryker Sustainability Solutions",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "244535",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10091",
      "drug_name": "CoreValve Evolut R Transcatheter Aortic Valve",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-09-30",
      "manufacturer": "Medtronic Corevalve LLC",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "249720",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10092",
      "drug_name": "Elecsys Anti-HBs II",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-09-19",
      "manufacturer": "Roche Diagnostics GMBH",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "250487",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10093",
      "drug_name": "Pantera Pro Coronary Dilatation Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-10-14",
      "manufacturer": "Biotronik AG",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "251280",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10094",
      "drug_name": "HTLV I/II (Donor Screening and Blood Screening)",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-09-16",
      "manufacturer": "Roche Diagnostics GmbH",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "251598",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10109",
      "drug_name": "IntellaTip MiFi Open-Irrigated Ablation Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-12-09",
      "manufacturer": "Boston Scientific Corporation",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "252821",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10095",
      "drug_name": "MVP Micro Vascular Plug System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-11-02",
      "manufacturer": "Reverse Medical Corporation",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "249535",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10096",
      "drug_name": "APTIMA HCV Quant Dx assay",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-09-14",
      "manufacturer": "Gen-Probe Incorporated, doing business as Hologic, Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "247266",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10115",
      "drug_name": "Biobrane Temporary Wound Dressing",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-01-11",
      "manufacturer": "Smith &amp; Nephew Medical Ltd.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "254720",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10097",
      "drug_name": "Ultra ICE Plus (intracardiac echo catheter)",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-10-21",
      "manufacturer": "Boston Scientific Corporation",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "254486",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10098",
      "drug_name": "Wolverine Coronary Cutting Balloon Microsurgical Dilatation Device",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-10-21",
      "manufacturer": "Boston Scientific Corporation",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "254686",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10099",
      "drug_name": "Proclaim Implantable Pulse Generators",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-04-26",
      "manufacturer": "St. Jude Medical",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "245524",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10100",
      "drug_name": "OSSIX VOLUMAX",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-11-16",
      "manufacturer": "Datum Dental Ltd.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "256745",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10101",
      "drug_name": "IN.PACT Admiral Paclitaxel-Coated PTA Balloon Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-11-15",
      "manufacturer": "Medtronic Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "234814",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10102",
      "drug_name": "Eluna 8",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-11-04",
      "manufacturer": "Biotronik SE & Co. KG",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "250081",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10103",
      "drug_name": "Advisor FL, Sensor Enabled Circular Mapping Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-11-15",
      "manufacturer": "St. Jude Medical",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "251549",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10104",
      "drug_name": "StrataMR Assemblies and Shunt Kits",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-11-16",
      "manufacturer": "Medtronic Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "252528",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10105",
      "drug_name": "StrataMR",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-11-16",
      "manufacturer": "Medtronic Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "252526",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10106",
      "drug_name": "Bridge Occlusion Balloon",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-11-22",
      "manufacturer": "Spectranetics Corporation",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "254548",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10107",
      "drug_name": "Procleix Panther System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-11-04",
      "manufacturer": "Gen-Probe Incorporated, doing business as Hologic, Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "256038",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10108",
      "drug_name": "NanoCross Elite 0.014\" (inch) Over-the-Wire PTA Balloon Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-12-06",
      "manufacturer": "EV3 Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "252513",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10110",
      "drug_name": "nMARQ Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-12-16",
      "manufacturer": "Biosense Webster Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "253097",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10111",
      "drug_name": "IntellaNav Open-Irrigated Ablation Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-12-16",
      "manufacturer": "Boston Scientific Corporation",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "255276",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10112",
      "drug_name": "OraQuick HCV Rapid Antibody Test",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-01-17",
      "manufacturer": "Orasure Technologies, Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "242912",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10113",
      "drug_name": "Gore Tigris Vascular Stent",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-01-11",
      "manufacturer": "W.L. Gore &amp; Associates Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "248949",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10114",
      "drug_name": "Comet Pressure Guidewire",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-01-09",
      "manufacturer": "Boston Scientific Corporation",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "252979",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10116",
      "drug_name": "Anastoclip GC Closure System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-01-19",
      "manufacturer": "Lemaitre Vascular, Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "257575",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10117",
      "drug_name": "FlexAbility Ablation Catheter, Sensor Enabled",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-01-27",
      "manufacturer": "St. Jude Medical",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "249718",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10118",
      "drug_name": "Foresight ICE System Intracardiac Echo Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-01-30",
      "manufacturer": "Conavi Medical Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "253597",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10119",
      "drug_name": "Xymphony Contour Adapting Resorbable Membrane",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-02-02",
      "manufacturer": "Kensey Nash Corporation B.A. DSM Biomedical",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "254154",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10120",
      "drug_name": "ZOLL AED 3",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-01-26",
      "manufacturer": "Zoll Medical Corporation",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "256691",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10121",
      "drug_name": "Pressure Injectable Multi-Lumen Central Venous Catheterization Kit",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-02-14",
      "manufacturer": "Arrow International, Inc. (Subsidiary of Teleflex, Incorporated)",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "257984",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10122",
      "drug_name": "Xience Alpine Everolimus Eluting Coronary Stent Syetem (EECSS)",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-02-07",
      "manufacturer": "Abbott Vascular",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "253673",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10123",
      "drug_name": "AspireAssist",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-03-14",
      "manufacturer": "Aspire Bariatrics Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "259608",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10124",
      "drug_name": "FlexiGRAFT Tendon Constructs",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-02-21",
      "manufacturer": "LifeNet Health",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "250876",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10125",
      "drug_name": "SalvinOss Xenograft Bone Graft Material",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-02-21",
      "manufacturer": "Kensey Nash Corporation D.B.A. DSM Biomedical",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "252787",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10126",
      "drug_name": "Indigo Aspiration System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-02-21",
      "manufacturer": "Penumbra Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "253958",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10127",
      "drug_name": "PressureWire X",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-02-23",
      "manufacturer": "St. Jude Medical",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "257410",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10128",
      "drug_name": "Ivascular Oceanus, PTA Balloon Dilatation Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-03-21",
      "manufacturer": "Life Vascular Devices Biotech S.L.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "251271",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10129",
      "drug_name": "Visia AF and Visia AF MRI",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-03-08",
      "manufacturer": "Medtronic Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "252441",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10130",
      "drug_name": "Impella RP Circulatory Support System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-03-08",
      "manufacturer": "ABIOMED Europe GmbH",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "254469",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10131",
      "drug_name": "Intellanav Temperature Ablation Catheters",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-03-16",
      "manufacturer": "Boston Scientific Corporation",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "255882",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10132",
      "drug_name": "MitraClip NT Clip Delivery System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-04-03",
      "manufacturer": "Abbott Vascular",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "260356",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10133",
      "drug_name": "Procleix Ultrio Elite Assay (Donor Screening/Cadaveric)",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-04-06",
      "manufacturer": "Gen-Probe Incorporated, doing business as Hologic, Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "256036",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10134",
      "drug_name": "Figulla Flex II ASD",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-04-07",
      "manufacturer": "Occlutech GMBH",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "251845",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10135",
      "drug_name": "Elecsys Anti-HBc II (Donor Screening and Blood Screening)",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-04-07",
      "manufacturer": "Roche Diagnostics GMBH",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "259535",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10136",
      "drug_name": "VIROTROL HBeAg",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-04-07",
      "manufacturer": "Bio-Rad Laboratories",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "263868",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10137",
      "drug_name": "Camino Intracranial Pressure Monitoring Catheter with LICOX IMC Bolt Fitting",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-04-20",
      "manufacturer": "Integra Lifesciences Corporation DBA Integra Neurosciences",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "253387",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10138",
      "drug_name": "PK Papyrus Covered Coronary Stent System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-04-25",
      "manufacturer": "Biotronik AG",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "250070",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10140",
      "drug_name": "Carelink Encore",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-04-20",
      "manufacturer": "Medtronic Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "261529",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10141",
      "drug_name": "Precision Montage Spinal Cord Stimulator System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-04-21",
      "manufacturer": "Boston Scientific Neuromodulation Corporation",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "263685",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10150",
      "drug_name": "Galaxy G3 XSFT Microcoil Delivery System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-06-15",
      "manufacturer": "MEDOS INTERNATIONAL SARL",
      "prescription_status": null,
      "type_submission": "New",
      "date_filed": null,
      "control_number": "263514",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10142",
      "drug_name": "Compia MRI CRT-D SureScan System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-05-02",
      "manufacturer": "Medtronic Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "251671",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10143",
      "drug_name": "Pacific Plus PTA Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-05-01",
      "manufacturer": "Medtronic Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "265389",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10144",
      "drug_name": "cobas MPX",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2016-06-30",
      "manufacturer": "Roche Diagnostics GmbH",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "237500",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10145",
      "drug_name": "MRI CRT-D SureScan",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-05-10",
      "manufacturer": "Medtronic Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "251673",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10199",
      "drug_name": "Proclaim DRG Implantable Pulse Generator",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-02-26",
      "manufacturer": "St. Jude Medical",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "272853",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10146",
      "drug_name": "Accurun HIV RNA Tri-Level Controls",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-05-16",
      "manufacturer": "Seracare Life Sciences, Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "264579",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10147",
      "drug_name": "Accurun HCV RNA Tri-level Controls",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-05-16",
      "manufacturer": "Seracare Life Sciences, Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "264954",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10148",
      "drug_name": "Accurun HBV RNA Tri-level Controls",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-05-16",
      "manufacturer": "Seracare Life Sciences, Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "264960",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10149",
      "drug_name": "Pacific Xtreme PTA Balloon Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-05-16",
      "manufacturer": "Medtronic Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "265528",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10163",
      "drug_name": "Reprocessed Daig Livewire Electrophysiology Catheters",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-09-01",
      "manufacturer": "STRYKER SUSTAINABILITY SOLUTIONS",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "260154",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10151",
      "drug_name": "FreeStyle Libre Flash Glucose Monitoring System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-06-27",
      "manufacturer": "Abbott Diabetes Care Ltd.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "246829",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10152",
      "drug_name": "LifeStream Balloon Expandable Vascular Covered Stent",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-08-31",
      "manufacturer": "CLEARSTREAM TECHNOLOGIES, LTD.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "268257",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10153",
      "drug_name": "Collagen Dural Regeneration Matrix",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-08-25",
      "manufacturer": "COLLAGEN MATRIX, INC.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "261988",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10154",
      "drug_name": "Duramatrix Suturable Collagen Dura Membrane",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-09-05",
      "manufacturer": "COLLAGEN MATRIX, INC.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "266273",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10155",
      "drug_name": "Lifepak CR2 Defibrillator",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-09-05",
      "manufacturer": "PHYSIO-CONTROL, INC.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "264263",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10156",
      "drug_name": "Amplazter Amulet Left Atrial Appendage Occluder",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-07-19",
      "manufacturer": "AGA MEDICAL CORPORATION",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "261253",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10157",
      "drug_name": "Codman Neuro Microcoil Delivery Systems",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-05-30",
      "manufacturer": "MEDOS INTERNATIONAL SARL",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "262203",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10158",
      "drug_name": "CUSA Clarity Ultrasonic Surgical Aspirator System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-05-30",
      "manufacturer": "INTEGRA LIFESCIENCES (IRELAND) LIMITED",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "261016",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10159",
      "drug_name": "Reprocessed IBI Diagnostic Electrophysiology Catheters",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-08-31",
      "manufacturer": "STRYKER SUSTAINABILITY SOLUTIONS",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "260160",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10160",
      "drug_name": "Reprocessed Diagnostic Electrophysiology Catheters",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-08-31",
      "manufacturer": "STRYKER SUSTAINABILITY SOLUTIONS",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "260159",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10161",
      "drug_name": "Reprocessed Bard Electrophysiology Catheters",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-08-31",
      "manufacturer": "STRYKER SUSTAINABILITY SOLUTIONS",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "260155",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10162",
      "drug_name": "Clinimacs Prodigy",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-07-19",
      "manufacturer": "MILTENYI BIOTEC GMBH",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "261772",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10164",
      "drug_name": "Reprocessed 3D Diagnostic Ultrasound Catheters",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-07-26",
      "manufacturer": "STERILMED, INC.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "258907",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10165",
      "drug_name": "Reprocessed Imaging Catheters",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-07-26",
      "manufacturer": "STERILMED, INC.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "258514",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10181",
      "drug_name": "Atellica IM Anti-Hepatitis B core Total (HBcT) Assay",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-12-07",
      "manufacturer": "SIEMENS HEALTHCARE DIAGNOSTICS INC.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "273372",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10166",
      "drug_name": "Jetstream Atherectomy System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-05-30",
      "manufacturer": "BAYER MEDICAL CARE INC.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "245589",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10167",
      "drug_name": "AC3 SERIES IABP SYSTEM",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-09-26",
      "manufacturer": "Arrow International, Inc. (Subsidiary of Teleflex, Incorporated)",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "269482",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10168",
      "drug_name": "The Graft Natural Bone Substitute Cancellous Granules",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-10-30",
      "manufacturer": "Purgo Biologics Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "269138",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10169",
      "drug_name": "InterStim II System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-09-08",
      "manufacturer": "Medtronic Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "268869",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10170",
      "drug_name": "CardioMEMS HF System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-10-13",
      "manufacturer": "St. Jude Medical",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "268643",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10171",
      "drug_name": "Single Chamber Temporary External Pacemaker",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-09-12",
      "manufacturer": "Medtronic Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "268549",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10172",
      "drug_name": "Reprocessed Diagnostic Ultrasound Catheters",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-10-19",
      "manufacturer": "Stryker Sustainability Solutions",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "260156",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10173",
      "drug_name": "Avalus Bioprosthesis",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-09-08",
      "manufacturer": "Medtronic Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "257049",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10174",
      "drug_name": "Silk Nonabsorbable Surgical Sutures",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-10-05",
      "manufacturer": "CP Medical, Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "267752",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10175",
      "drug_name": "ACCESS HCV AB V3 (DONOR SCREENING)",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-11-27",
      "manufacturer": "BIO-RAD",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "268263",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10176",
      "drug_name": "Bovine Dermis Collagen Dental Wound Dressings",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-11-27",
      "manufacturer": "COLLAGEN MATRIX, INC.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "268979",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10177",
      "drug_name": "Alinity i HBsAg Qualitative II Assay",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-11-28",
      "manufacturer": "ABBOTT IRELAND, DIAGNOSTICS DIVISION",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "269409",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10178",
      "drug_name": "Alinity i HBsAg Qualitative Confirmatory Assay",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-11-27",
      "manufacturer": "ABBOTT IRELAND, DIAGNOSTICS DIVISION",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "269405",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10185",
      "drug_name": "Inspiris Resilia Aortic Valve",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-12-28",
      "manufacturer": "Edwards Lifesciences LLC",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "267649",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10179",
      "drug_name": "Vercise Gevia Deep Brain Stimulation System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-12-07",
      "manufacturer": "BOSTON SCIENTIFIC NEUROMODULATION CORPORATION",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "268981",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10180",
      "drug_name": "Intellanav MiFi Open-Irrigated Ablation Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-12-01",
      "manufacturer": "BOSTON SCIENTIFIC CORPORATION",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "272892",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10198",
      "drug_name": "MatriDerm Dermal Matrix",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-02-28",
      "manufacturer": "Medskin Solutions Dr. Suwelack AG",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "255707",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10182",
      "drug_name": "ProGrip laparoscopic self-fixating mesh",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-12-14",
      "manufacturer": "SOFRADIM PRODUCTION",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "269996",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10183",
      "drug_name": "E-Pack Procedure Kits",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-12-18",
      "manufacturer": "Ethicon Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "269413",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10184",
      "drug_name": "Pulsar-35 Peripheral Self-Expanding Nitinol Stent System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-12-28",
      "manufacturer": "BIOTRONIK AG",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "268253",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10186",
      "drug_name": "Edwards Pericardial Aortic Bioprosthesis",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2017-12-28",
      "manufacturer": "Edwards Lifesciences LLC",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "267094",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10187",
      "drug_name": "OCS-B Collagen Spongious Bone Substitute (Bovine) with Collagen",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-02-06",
      "manufacturer": "NIBEC CO., LTD.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "273158",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10188",
      "drug_name": "Alinity i Anti-HBc II",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-01-15",
      "manufacturer": "ABBOTT GMBH & CO. K.G.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "269720",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10189",
      "drug_name": "Pulsar-18 Peripheral Self-Expanding Nitinol Stent System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-01-22",
      "manufacturer": "BIOTRONIK AG",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "268252",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10190",
      "drug_name": "HeartMate 3 Left Ventricular Assist System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-01-17",
      "manufacturer": "THORATEC CORPORATION",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "276620",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10191",
      "drug_name": "Acurate neo Aortic Bioprosthesis and Acurate TF Transfemoral Delivery System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-02-16",
      "manufacturer": "Symetis SA",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "266412",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10192",
      "drug_name": "OptiCross 18 30MHz Peripheral Imaging Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-02-13",
      "manufacturer": "Boston Scientific Corporation",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "269048",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10193",
      "drug_name": "Endoform Dermal Template",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-02-13",
      "manufacturer": "Aroa Biosurgery Ltd.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "269932",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10194",
      "drug_name": "FRED PA-1",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-02-13",
      "manufacturer": "Schiller Medical",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "269154",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10195",
      "drug_name": "TactiCath Contact Force Ablation Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-02-12",
      "manufacturer": "St. Jude Medical",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "274631",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10196",
      "drug_name": "Astra/Azure MRI Surescan Pacing System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-03-07",
      "manufacturer": "Medtronic Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "273313",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10197",
      "drug_name": "DRG Leads and Accessories",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-03-06",
      "manufacturer": "St. Jude Medical",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "273771",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10200",
      "drug_name": "Lead and Extension Kits for Deep Brain Stimulation (DBS) Systems",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-03-12",
      "manufacturer": "St. Jude Medical",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "272175",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10201",
      "drug_name": "Guardian Cranial Burr Hole Cover System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-03-13",
      "manufacturer": "St. Jude Medical",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "272136",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10202",
      "drug_name": "Infinity Implantable Pulse Generator",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-03-13",
      "manufacturer": "St. Jude Medical",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "272122",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10203",
      "drug_name": "Reprocessed Lasso Electrophysiology Catheters",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-04-04",
      "manufacturer": "Sterilmed, Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "272545",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10204",
      "drug_name": "Intellis Neurostimulation System with Wireless External Neurostimulator",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-04-10",
      "manufacturer": "Medtronic Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "273197",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10205",
      "drug_name": "Edora 8 Implantable Pulse Generator",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-04-11",
      "manufacturer": "BIOTRONIK SE & CO. KG",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "270971",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10206",
      "drug_name": "Ilivia 7 CRT-D",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-04-11",
      "manufacturer": "Biotronik SE & Co. KG",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "268806",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10207",
      "drug_name": "Latitude Programming System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-04-04",
      "manufacturer": "Boston Scientific Corporation",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "277643",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10208",
      "drug_name": "CRT-P MRI Surescan",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-04-30",
      "manufacturer": "Medtronic Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "273307",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10209",
      "drug_name": "Guardian Connect Continuous Glucose Monitoring System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-05-09",
      "manufacturer": "Medtronic Minimed",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "268421",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10210",
      "drug_name": "Cytal",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-05-10",
      "manufacturer": "Acell, Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "271310",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10211",
      "drug_name": "Advisor HD Grid Mapping Catheter, Sensor Enabled",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-05-08",
      "manufacturer": "St. Jude Medical",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "273545",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10212",
      "drug_name": "Geistlich Fibro-Gide Collagen Matrix",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-05-15",
      "manufacturer": "Geistlich Pharma AG",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "273725",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10213",
      "drug_name": "Alinity I Syphilis TP Assay (Donor Screening & Cadaveric Testing)",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-05-14",
      "manufacturer": "Abbott GmbH & Co. K.G.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "273902",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10214",
      "drug_name": "Alinity i Anti-HBc IGM Assay",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-05-15",
      "manufacturer": "Abbott GmbH & Co. K.G.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "271060",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10215",
      "drug_name": "Ossix Bone - Bone Grafting Material Featuring Glymatrix",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-05-14",
      "manufacturer": "Datum Dental Ltd.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "274765",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10216",
      "drug_name": "Tigertriever Revascularization Device",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-05-22",
      "manufacturer": "Rapid Medical Ltd.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "269152",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10217",
      "drug_name": "Reprocessed Sealed Electrophysiology Diagnostic Catheters",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-05-15",
      "manufacturer": "Sterilmed, Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "270800",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10218",
      "drug_name": "Plain and Chromic Gut Absorbable Surgical Sutures",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-05-31",
      "manufacturer": "CP Medical, Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "267757",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10219",
      "drug_name": "Pheonix Atherectomy System",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-06-12",
      "manufacturer": "Volcano Atheromed, Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "280990",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10220",
      "drug_name": "Alinity I Chagas Assay (Donor Screening/Cadaveric)",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-06-14",
      "manufacturer": "Abbott GmbH & Co. K.G.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "280595",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10221",
      "drug_name": "Artemis Neuro Evacuation Device",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-06-12",
      "manufacturer": "Penumbra Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "275828",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10222",
      "drug_name": "Natrelle 410 Truform Microcell Silicone-Filled Breast Implants",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-06-19",
      "manufacturer": "Allergan",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "273494",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10223",
      "drug_name": "Natrelle Inspira Truform 1 Microcell Breast Implants",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-06-19",
      "manufacturer": "Allergan",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "273495",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10224",
      "drug_name": "Micromatrix",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-06-19",
      "manufacturer": "Acell, Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "274752",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10225",
      "drug_name": "Natrelle Inspira Truform 2 Microcell Breast Implants",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-06-19",
      "manufacturer": "Allergan",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "273496",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10226",
      "drug_name": "Alinity I HIV AG/AB Combo Assay (Donor Screening and Cadaveric Testing)",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-06-20",
      "manufacturer": "Abbott GmbH & Co. K.G.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "272821",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10227",
      "drug_name": "Refinity Rotational Intravascular Ultrasound (IVUS) Catheter",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-07-06",
      "manufacturer": "Volcano Corporation",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "272810",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    },
    {
      "link_id": "RDS10228",
      "drug_name": "Codman Enterprise 2 Vascular Reconstruction Device",
      "contact_name": null,
      "contact_url": null,
      "medical_ingredient": "N/A",
      "therapeutic_area": null,
      "purpose": null,
      "reason_decision": null,
      "decision": "Approved",
      "decision_descr": null,
      "date_decision": "2018-06-29",
      "manufacturer": "Codman & Shurtleff Inc.",
      "prescription_status": null,
      "type_submission": "New device licence application",
      "date_filed": null,
      "control_number": "279797",
      "application_number": null,
      "application_type": null,
      "licence_num": null,
      "device_class": null,
      "created_date": null,
      "modified_date": null,
      "footnotes": 0,
      "summary_title": null,
      "summary_subtitle": null,
      "summary_text1": null,
      "summary_text2": null,
      "summary_text3": null,
      "din": null,
      "is_md": true,
      "din_list": null,
      "bullet_list": null
    }
  ]
}